PDK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00141 | S422 | SIGNOR|ELM|EPSD | SGK1 SGK | PDsVLVTAsVKEAAEAFLGFsYAPPTDSFL___________ |
| O00141 | T256 | SIGNOR|ELM|EPSD|PSP | SGK1 SGK | IVLTDFGLCKENIEHNsTtstFCGtPEyLAPEVLHKQPYDR |
| O14920 | S181 | EPSD | IKBKB IKKB | IHKIIDLGYAKELDQGsLCTsFVGTLQyLAPELLEQQKyTV |
| O15530 | S241 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PDPK1 PDK1 | ITDFGTAKVLSPESKQARANsFVGtAQYVSPELLTEKSACK |
| O15530 | S25 | SIGNOR|ELM|EPSD|PSP | PDPK1 PDK1 | TSQLyDAVPIQSSVVLCSCPsPSMVRTQtESstPPGIPGGS |
| O15530 | S393 | SIGNOR|ELM|EPSD|PSP | PDPK1 PDK1 | yGNyDNLLSQFGCMQVSSSSssHsLsASDTGLPQRSGsNIE |
| O15530 | S396 | SIGNOR|ELM|EPSD|PSP | PDPK1 PDK1 | yDNLLSQFGCMQVSSSSssHsLsASDTGLPQRSGsNIEQYI |
| O15530 | S410 | SIGNOR|ELM|EPSD|PSP | PDPK1 PDK1 | SSSssHsLsASDTGLPQRSGsNIEQYIHDLDSNSFELDLQF |
| O15530 | T33 | iPTMNet|EPSD | PDPK1 PDK1 | PIQSSVVLCSCPsPSMVRTQtESstPPGIPGGSRQGPAMDG |
| O15530 | T513 | ELM|iPTMNet|EPSD|PSP | PDPK1 PDK1 | VLKGEIPWSQELRPEAKNFKtFFVHTPNRTYYLMDPSGNAH |
| O43865 | S68 | SIGNOR | AHCYL1 DCAL IRBIT XPVKONA | MQEFTKFPTKTGRRSLSRsIsQSsTDsySsAASYTDssDDE |
| O60331 | S448 | EPSD|PSP | PIP5K1C KIAA0589 | PSFYAERFFKFMSNTVFRKNsSLKSsPSKKGRGGALLAVKP |
| P00558 | T243 | SIGNOR|PSP | PGK1 PGKA MIG10 OK/SW-cl.110 | LINNMLDKVNEMIIGGGMAFtFLKVLNNMEIGTsLFDEEGA |
| P05106 | T777 | ELM|EPSD | ITGB3 GP3A | EEERARAKWDtANNPLyKEAtstFtNItyRGt_________ |
| P05106 | T779 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ITGB3 GP3A | ERARAKWDtANNPLyKEAtstFtNItyRGt___________ |
| P05771 | T500 | SIGNOR | PRKCB PKCB PRKCB1 | IKIADFGMCKENIWDGVttKtFCGtPDyIAPEIIAyQPYGK |
| P08559 | S232 | EPSD | PDHA1 PHE1A | ALWKLPCIFICENNRYGMGtsVERAAAsTDYYKRGDFIPGL |
| P08559 | S293 | EPSD|PSP | PDHA1 PHE1A | CRSGKGPILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsK |
| P08559 | S300 | EPSD | PDHA1 PHE1A | ILMELQTYRyHGHsMsDPGVsyRtREEIQEVRsKsDPIMLL |
| P10636 | S46 | EPSD | MAPT MAPTL MTBT1 TAU | QGGytMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDA |
| P10636 | S515 | EPSD | MAPT MAPTL MTBT1 TAU | APKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtP |
| P10636 | S516 | EPSD | MAPT MAPTL MTBT1 TAU | PKtPPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPP |
| P10636 | S519 | EPSD | MAPT MAPTL MTBT1 TAU | PPsSGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTRE |
| P10636 | S552 | EPSD | MAPT MAPTL MTBT1 TAU | LPtPPTREPKKVAVVRtPPKsPssAKSRLQTAPVPMPDLKN |
| P10636 | S739 | EPSD | MAPT MAPTL MTBT1 TAU | DtsPRHLsNVsstGsIDMVDsPQLAtLADEVSASLAKQGL_ |
| P10636 | T470 | EPSD | MAPT MAPTL MTBT1 TAU | GSSGAKEMKLKGADGKTKIAtPRGAAPPGQKGQANATRIPA |
| P10636 | T492 | EPSD | MAPT MAPTL MTBT1 TAU | RGAAPPGQKGQANATRIPAKtPPAPKtPPsSGEPPKsGDRs |
| P10636 | T498 | EPSD | MAPT MAPTL MTBT1 TAU | GQKGQANATRIPAKtPPAPKtPPsSGEPPKsGDRsGyssPG |
| P10636 | T50 | EPSD | MAPT MAPTL MTBT1 TAU | tMHQDQEGDtDAGLKEsPLQtPTEDGsEEPGsETSDAKstP |
| P10636 | T522 | EPSD | MAPT MAPTL MTBT1 TAU | SGEPPKsGDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKK |
| P10636 | T529 | EPSD | MAPT MAPTL MTBT1 TAU | GDRsGyssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtP |
| P10636 | T534 | EPSD | MAPT MAPTL MTBT1 TAU | yssPGsPGtPGsRsRtPsLPtPPTREPKKVAVVRtPPKsPs |
| P17600 | S551 | EPSD | SYN1 | RQSRPVAGGPGAPPAARPPAsPsPQRQAGPPQATRQTsVSG |
| P17612 | T198 | EPSD|PSP | PRKACA PKACA | QGYIQVTDFGFAKRVKGRtWtLCGtPEYLAPEIILsKGYNK |
| P23443 | S394 | PSP | RPS6KB1 STK14A | QsEEDVsQFDSKFtRQtPVDsPDDstLsEsANQVFLGFtYV |
| P23443 | S427 | ELM|EPSD | RPS6KB1 STK14A | VFLGFtYVAPSVLESVKEKFsFEPKIRsPRRFIGsPRtPVs |
| P23443 | T252 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KB1 STK14A | VKLTDFGLCKEsIHDGTVtHtFCGTIEYMAPEILMRSGHNR |
| P23443 | T390 | EPSD | RPS6KB1 STK14A | KPLLQsEEDVsQFDSKFtRQtPVDsPDDstLsEsANQVFLG |
| P23443 | T412 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RPS6KB1 STK14A | VDsPDDstLsEsANQVFLGFtYVAPSVLESVKEKFsFEPKI |
| P31749 | S473 | SIGNOR|ELM|EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | T308 | SIGNOR|ELM|EPSD|PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31751 | S474 | SIGNOR|EPSD | AKT2 | DRyDsLGLLELDQRTHFPQFsysAsIRE_____________ |
| P31751 | T309 | SIGNOR|ELM|EPSD|PSP | AKT2 | IKITDFGLCKEGISDGATMKtFCGtPEyLAPEVLEDNDyGR |
| P31946 | S60 | ELM | YWHAB | NEERNLLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQM |
| P36507 | S226 | SIGNOR|ELM|EPSD|PSP | MAP2K2 MEK2 MKK2 PRKMK2 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGTHYSV |
| P51812 | S227 | SIGNOR | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | IKLTDFGLSKESIDHEKKAysFCGtVEYMAPEVVNRRGHTQ |
| Q02156 | T566 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKCE PKCE | CKLADFGMCKEGILNGVTTTtFCGTPDyIAPEILQELEYGP |
| Q02750 | S222 | SIGNOR|ELM|EPSD|PSP | MAP2K1 MEK1 PRKMK1 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGTHYSV |
| Q04917 | S59 | ELM | YWHAH YWHA1 | NEDRNLLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKL |
| Q05513 | T410 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKCZ PKC2 | IKLTDYGMCKEGLGPGDTTstFCGTPNyIAPEILRGEEyGF |
| Q05655 | T507 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKCD PKCD | IKIADFGMCKENIFGEsRAstFCGtPDyIAPEILQGLKyTF |
| Q13153 | T423 | SIGNOR|ELM|iPTMNet|EPSD|PSP | PAK1 | VKLTDFGFCAQITPEQSKRstMVGTPYWMAPEVVTRKAYGP |
| Q15118 | S25 | EPSD | PDK1 PDHK1 | RLLRGAALAGPGPGLRAAGFsRsFsSDSGSSPASERGVPGQ |
| Q15118 | S393 | EPSD | PDK1 PDHK1 | LKLYSLEGYGTDAVIYIKALsTDsIERLPVyNKAAWKHyNt |
| Q15118 | S396 | EPSD | PDK1 PDHK1 | YSLEGYGTDAVIYIKALsTDsIERLPVyNKAAWKHyNtNHE |
| Q15349 | S218 | EPSD | RPS6KA2 MAPKAPK1C RSK3 | IKITDFGLSKEAIDHDKRAYsFCGtIEYMAPEVVNRRGHTQ |
| Q15418 | S221 | SIGNOR|ELM|EPSD|PSP | RPS6KA1 MAPKAPK1A RSK1 | IKLTDFGLSKEAIDHEKKAysFCGtVEYMAPEVVNRQGHSH |
| Q16512 | S773 | EPSD|PSP | PKN1 PAK1 PKN PRK1 PRKCL1 | YVKIADFGLCKEGMGyGDRtstFCGtPEFLAPEVLTDTSYT |
| Q16512 | T774 | SIGNOR|ELM|EPSD|PSP | PKN1 PAK1 PKN PRK1 PRKCL1 | VKIADFGLCKEGMGyGDRtstFCGtPEFLAPEVLTDTSYTR |
| Q16513 | T816 | SIGNOR|ELM|EPSD|PSP | PKN2 PRK2 PRKCL2 | VKIADFGLCKEGMGYGDRtstFCGtPEFLAPEVLTETSYTR |
| Q16513 | T951 | EPSD | PKN2 PRK2 PRKCL2 | PPFIPTIRGREDVSNFDDEFtsEAPILtPPREPRILsEEEQ |
| Q96BR1 | S486 | SIGNOR|iPTMNet|EPSD | SGK3 CISK SGKL | SDYSIVNASVLEADDAFVGFsYAPPSEDLFL__________ |
| Q96BR1 | T320 | SIGNOR|ELM|iPTMNet|EPSD|PSP | SGK3 CISK SGKL | VVLTDFGLCKEGIAISDTTTtFCGTPEYLAPEVIRKQPYDN |
| Q96PN8 | T168 | SIGNOR | TSSK3 SPOGA3 STK22C | KLTDFGFAKVLPKSHRELsQtFCGSTAYAAPEVLQGIPHDS |
| Q99683 | S966 | EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | KTQPKLSALSAGsNEYLRsIsLPVPVLVEDtssssEYGsVs |
| Q99683 | T838 | ELM|EPSD | MAP3K5 ASK1 MAPKKK5 MEKK5 | LKISDFGtSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGY |
| Q99814 | T324 | EPSD|PSP | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | SGQYRMLAKHGGYVWLETQGtVIYNPRNLQPQCIMCVNYVL |
| Q9HBY8 | T193 | SIGNOR | SGK2 | VVLTDFGLCKEGVEPEDTTStFCGTPEYLAPEVLRKEPYDR |
| Q9UBS0 | S370 | SIGNOR|EPSD | RPS6KB2 STK14B | QSEEDVSQFDTRFTRQTPVDsPDDTALSESANQAFLGFtYV |
| Q9UBS0 | T228 | SIGNOR|EPSD | RPS6KB2 STK14B | IKLTDFGLCKESIHEGAVTHtFCGTIEYMAPEILVRSGHNR |
| Q9UBS0 | T388 | SIGNOR|EPSD | RPS6KB2 STK14B | VDsPDDTALSESANQAFLGFtYVAPSVLDSIKEGFsFQPKL |
| Q9Y243 | S120 | EPSD | AKT3 PKBG | EAIQAVADRLQRQEEERMNCsPtsQIDNIGEEEMDAsTtHH |
| Q9Y243 | T305 | SIGNOR|ELM|EPSD|PSP | AKT3 PKBG | IKITDFGLCKEGITDAATMKtFCGtPEyLAPEVLEDNDyGR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| L1CAM interactions | R-HSA-373760 | 1.601388e-10 | 9.796 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.091408e-10 | 9.388 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.064449e-09 | 8.391 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.262552e-08 | 7.899 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.400929e-08 | 7.268 | 1 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.606325e-07 | 6.794 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.190533e-07 | 6.208 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.666050e-06 | 5.778 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.130998e-06 | 5.671 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.784863e-06 | 5.320 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.485129e-06 | 5.261 | 1 | 1 |
| Signaling by Hippo | R-HSA-2028269 | 5.861182e-06 | 5.232 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.905102e-06 | 5.161 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.575507e-06 | 5.182 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.987690e-06 | 5.156 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.522709e-05 | 4.817 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.728831e-05 | 4.762 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.995422e-05 | 4.700 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.481376e-05 | 4.349 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.481376e-05 | 4.349 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.687297e-05 | 4.245 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.521705e-05 | 4.258 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.670235e-05 | 4.115 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.131902e-04 | 3.946 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.131902e-04 | 3.946 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.112356e-04 | 3.954 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.229021e-04 | 3.910 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.211737e-04 | 3.917 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.362688e-04 | 3.866 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.494234e-04 | 3.826 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.498147e-04 | 3.824 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.781369e-04 | 3.749 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.804884e-04 | 3.744 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.533556e-04 | 3.596 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.494002e-04 | 3.603 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.607240e-04 | 3.584 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.644440e-04 | 3.578 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.784003e-04 | 3.555 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.394404e-04 | 3.469 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.398809e-04 | 3.469 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.648696e-04 | 3.438 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.535733e-04 | 3.452 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.587237e-04 | 3.445 | 1 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.992031e-04 | 3.399 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.332344e-04 | 3.363 | 1 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.031627e-04 | 3.298 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.988303e-04 | 3.302 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.100910e-04 | 3.292 | 1 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.380813e-04 | 3.195 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.270545e-04 | 3.203 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.073881e-04 | 3.217 | 1 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.210243e-04 | 3.086 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.210243e-04 | 3.086 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.946390e-04 | 3.100 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.733697e-04 | 3.112 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.946390e-04 | 3.100 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.863202e-04 | 3.104 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.478719e-04 | 3.072 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.062345e-03 | 2.974 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.021144e-03 | 2.991 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.069844e-03 | 2.971 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.069844e-03 | 2.971 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.146483e-03 | 2.941 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.146886e-03 | 2.940 | 1 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.143898e-03 | 2.942 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.335159e-03 | 2.874 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.332646e-03 | 2.875 | 1 | 1 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.332646e-03 | 2.875 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.311808e-03 | 2.882 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.325570e-03 | 2.878 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.635301e-03 | 2.786 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.688672e-03 | 2.772 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.826081e-03 | 2.738 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.808909e-03 | 2.743 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.876413e-03 | 2.727 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.814477e-03 | 2.741 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.937394e-03 | 2.713 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.236354e-03 | 2.650 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.277452e-03 | 2.643 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.498969e-03 | 2.602 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.539933e-03 | 2.595 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.744543e-03 | 2.562 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.846899e-03 | 2.546 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.978762e-03 | 2.526 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.076988e-03 | 2.512 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.090159e-03 | 2.510 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.367434e-03 | 2.473 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.199104e-03 | 2.495 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.394155e-03 | 2.469 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.238995e-03 | 2.490 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.432446e-03 | 2.464 | 1 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.442501e-03 | 2.463 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.746053e-03 | 2.426 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.101839e-03 | 2.387 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.835157e-03 | 2.416 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.811865e-03 | 2.419 | 1 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 3.830321e-03 | 2.417 | 1 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.101839e-03 | 2.387 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.216009e-03 | 2.375 | 1 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.546135e-03 | 2.342 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.981644e-03 | 2.303 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.059365e-03 | 2.296 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.059365e-03 | 2.296 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.981644e-03 | 2.303 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.918452e-03 | 2.308 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.059365e-03 | 2.296 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.862209e-03 | 2.313 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.238942e-03 | 2.281 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.862209e-03 | 2.313 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.246222e-03 | 2.280 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.383561e-03 | 2.269 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.239820e-03 | 2.205 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.419196e-03 | 2.193 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.830817e-03 | 2.166 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.550481e-03 | 2.184 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.140948e-03 | 2.146 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.140948e-03 | 2.146 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.547361e-03 | 2.184 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.830817e-03 | 2.166 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.232952e-03 | 2.141 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.235734e-03 | 2.141 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 7.368814e-03 | 2.133 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.549431e-03 | 2.122 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.679966e-03 | 2.115 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 9.146139e-03 | 2.039 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.336190e-03 | 2.079 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.602631e-03 | 2.065 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.389865e-03 | 2.076 | 1 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.336190e-03 | 2.079 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.119657e-03 | 2.040 | 1 | 1 |
| Gap junction assembly | R-HSA-190861 | 8.602631e-03 | 2.065 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.201504e-03 | 2.036 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.746690e-03 | 2.011 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.848243e-03 | 2.007 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.001330e-02 | 1.999 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.062408e-02 | 1.974 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.083707e-02 | 1.965 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.083707e-02 | 1.965 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.087452e-02 | 1.964 | 1 | 1 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.112405e-02 | 1.954 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.180398e-02 | 1.928 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.274189e-02 | 1.895 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.274189e-02 | 1.895 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.274189e-02 | 1.895 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.260027e-02 | 1.900 | 1 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.357728e-02 | 1.867 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.245232e-02 | 1.905 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.275028e-02 | 1.894 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.379532e-02 | 1.860 | 1 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.379593e-02 | 1.860 | 1 | 1 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.389528e-02 | 1.857 | 1 | 1 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.437735e-02 | 1.842 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.468449e-02 | 1.833 | 1 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.486064e-02 | 1.828 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 1.486064e-02 | 1.828 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.486064e-02 | 1.828 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.533975e-02 | 1.814 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.586345e-02 | 1.800 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.644974e-02 | 1.784 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.652421e-02 | 1.782 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.683970e-02 | 1.774 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.738965e-02 | 1.760 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.738965e-02 | 1.760 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.894608e-02 | 1.722 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.719191e-02 | 1.765 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.832304e-02 | 1.737 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.894608e-02 | 1.722 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.894608e-02 | 1.722 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.940851e-02 | 1.712 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.940851e-02 | 1.712 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.030797e-02 | 1.692 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.073841e-02 | 1.683 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.073841e-02 | 1.683 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.534502e-02 | 1.596 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.249244e-02 | 1.648 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.547635e-02 | 1.594 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.547635e-02 | 1.594 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.362372e-02 | 1.627 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.219505e-02 | 1.654 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.256606e-02 | 1.647 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.219505e-02 | 1.654 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.449907e-02 | 1.611 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.531309e-02 | 1.597 | 1 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.647778e-02 | 1.577 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.647778e-02 | 1.577 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.647778e-02 | 1.577 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.713089e-02 | 1.567 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.713089e-02 | 1.567 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.713089e-02 | 1.567 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.713089e-02 | 1.567 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.713089e-02 | 1.567 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.868991e-02 | 1.542 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.874869e-02 | 1.541 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.921806e-02 | 1.534 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.989682e-02 | 1.524 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.095174e-02 | 1.509 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.101850e-02 | 1.508 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.116984e-02 | 1.506 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.116984e-02 | 1.506 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.145900e-02 | 1.502 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.212788e-02 | 1.493 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.332695e-02 | 1.477 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.332695e-02 | 1.477 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.592914e-02 | 1.445 | 1 | 1 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.579984e-02 | 1.446 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.748721e-02 | 1.426 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.982622e-02 | 1.400 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 3.588239e-02 | 1.445 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.510503e-02 | 1.455 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.707936e-02 | 1.431 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.707936e-02 | 1.431 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.650863e-02 | 1.438 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.910722e-02 | 1.408 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.592914e-02 | 1.445 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.579984e-02 | 1.446 | 1 | 1 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.581716e-02 | 1.446 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.626767e-02 | 1.440 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.176576e-02 | 1.379 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.221856e-02 | 1.374 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.225848e-02 | 1.374 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.386446e-02 | 1.358 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.463861e-02 | 1.350 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.463861e-02 | 1.350 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.463861e-02 | 1.350 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.478497e-02 | 1.349 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 4.566292e-02 | 1.340 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.641740e-02 | 1.333 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.641740e-02 | 1.333 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.765688e-02 | 1.322 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.765688e-02 | 1.322 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.896905e-02 | 1.310 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.928663e-02 | 1.307 | 1 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.012407e-02 | 1.300 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.130125e-02 | 1.290 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.148024e-02 | 1.288 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.201081e-02 | 1.284 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.281369e-02 | 1.277 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.281369e-02 | 1.277 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.292886e-02 | 1.276 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.293815e-02 | 1.276 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.386277e-02 | 1.269 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.393227e-02 | 1.268 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.393227e-02 | 1.268 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.393227e-02 | 1.268 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.393227e-02 | 1.268 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.757443e-02 | 1.170 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.757443e-02 | 1.170 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.058188e-02 | 1.218 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.885835e-02 | 1.230 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.203205e-02 | 1.207 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.757443e-02 | 1.170 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.657262e-02 | 1.247 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.882662e-02 | 1.230 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.058188e-02 | 1.218 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.695030e-02 | 1.245 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.624008e-02 | 1.250 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.270657e-02 | 1.203 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.799294e-02 | 1.168 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.799294e-02 | 1.168 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.811164e-02 | 1.167 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.093622e-02 | 1.149 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.173517e-02 | 1.144 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.183626e-02 | 1.144 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.183626e-02 | 1.144 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 8.099302e-02 | 1.092 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 8.099302e-02 | 1.092 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 8.099302e-02 | 1.092 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.958547e-02 | 1.099 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.958547e-02 | 1.099 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.958547e-02 | 1.099 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.958547e-02 | 1.099 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 9.219805e-02 | 1.035 | 1 | 1 |
| Lipophagy | R-HSA-9613354 | 9.219805e-02 | 1.035 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.219805e-02 | 1.035 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.495808e-02 | 1.125 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.517356e-02 | 1.070 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 9.132765e-02 | 1.039 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.113400e-02 | 1.091 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.113400e-02 | 1.091 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.113400e-02 | 1.091 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.329090e-02 | 1.079 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.329090e-02 | 1.079 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.655706e-02 | 1.015 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.036525e-02 | 1.044 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.653045e-02 | 1.116 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.113400e-02 | 1.091 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.115439e-02 | 1.040 | 1 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.113400e-02 | 1.091 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.350201e-02 | 1.134 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.923021e-02 | 1.101 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.495808e-02 | 1.125 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.639299e-02 | 1.016 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.639299e-02 | 1.016 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.537815e-02 | 1.123 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.219805e-02 | 1.035 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.495808e-02 | 1.125 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.495808e-02 | 1.125 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.977295e-02 | 1.047 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.742219e-02 | 1.058 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.219805e-02 | 1.035 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.517356e-02 | 1.070 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.472595e-02 | 1.127 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.615721e-02 | 1.065 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.958547e-02 | 1.099 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.219805e-02 | 1.035 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.699099e-02 | 1.061 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.693066e-02 | 1.014 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.504713e-02 | 1.125 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.036525e-02 | 1.044 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.481131e-02 | 1.023 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.226417e-02 | 1.085 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.958547e-02 | 1.099 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.517356e-02 | 1.070 | 1 | 1 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.907608e-02 | 1.102 | 1 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.517356e-02 | 1.070 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.517356e-02 | 1.070 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.768769e-02 | 1.010 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.768769e-02 | 1.010 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.811832e-02 | 1.008 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.902098e-02 | 1.004 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.902098e-02 | 1.004 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.902098e-02 | 1.004 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.189988e-01 | 0.924 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.189988e-01 | 0.924 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.189988e-01 | 0.924 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.189988e-01 | 0.924 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.554350e-01 | 0.808 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.554350e-01 | 0.808 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.554350e-01 | 0.808 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.554350e-01 | 0.808 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.554350e-01 | 0.808 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.554350e-01 | 0.808 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.554350e-01 | 0.808 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.053420e-01 | 0.977 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.053420e-01 | 0.977 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.053420e-01 | 0.977 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.189521e-01 | 0.925 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.329673e-01 | 0.876 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.329673e-01 | 0.876 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.329673e-01 | 0.876 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.473311e-01 | 0.832 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.473311e-01 | 0.832 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.473311e-01 | 0.832 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.473311e-01 | 0.832 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.076521e-01 | 0.968 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.351669e-01 | 0.869 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.351669e-01 | 0.869 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 1.351669e-01 | 0.869 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.179506e-01 | 0.928 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.323868e-01 | 0.878 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.398645e-01 | 0.854 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.475064e-01 | 0.831 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.188153e-01 | 0.925 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.553058e-01 | 0.809 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.553058e-01 | 0.809 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.315493e-01 | 0.881 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.425273e-01 | 0.846 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.053420e-01 | 0.977 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.475064e-01 | 0.831 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.179506e-01 | 0.928 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.053420e-01 | 0.977 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.448278e-01 | 0.839 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.165637e-01 | 0.933 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.329673e-01 | 0.876 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.370942e-01 | 0.863 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.475064e-01 | 0.831 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.189521e-01 | 0.925 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.448278e-01 | 0.839 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.553058e-01 | 0.809 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.137955e-01 | 0.944 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.225594e-01 | 0.912 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.262180e-01 | 0.899 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.262180e-01 | 0.899 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.547074e-01 | 0.810 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.053420e-01 | 0.977 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.473311e-01 | 0.832 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.158809e-01 | 0.936 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.148935e-01 | 0.940 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.042486e-01 | 0.982 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.148935e-01 | 0.940 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.264934e-01 | 0.898 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 1.554350e-01 | 0.808 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.554350e-01 | 0.808 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.189521e-01 | 0.925 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.264934e-01 | 0.898 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.272438e-01 | 0.895 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.225594e-01 | 0.912 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.100841e-01 | 0.958 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.083246e-01 | 0.965 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.473311e-01 | 0.832 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.473311e-01 | 0.832 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.473311e-01 | 0.832 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.553058e-01 | 0.809 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.262180e-01 | 0.899 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.112769e-01 | 0.954 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.481697e-01 | 0.829 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.473311e-01 | 0.832 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.189988e-01 | 0.924 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.547074e-01 | 0.810 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.189521e-01 | 0.925 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.165637e-01 | 0.933 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.444340e-01 | 0.840 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.323868e-01 | 0.878 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.262180e-01 | 0.899 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.158809e-01 | 0.936 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.427881e-01 | 0.845 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.105514e-01 | 0.956 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.250800e-01 | 0.903 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.053420e-01 | 0.977 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.179506e-01 | 0.928 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.554350e-01 | 0.808 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.329673e-01 | 0.876 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.255048e-01 | 0.901 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 1.448278e-01 | 0.839 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.448278e-01 | 0.839 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.448278e-01 | 0.839 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.390781e-01 | 0.857 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.547074e-01 | 0.810 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.189521e-01 | 0.925 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.323868e-01 | 0.878 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.370942e-01 | 0.863 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.292155e-01 | 0.889 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.110048e-01 | 0.955 | 1 | 1 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.323868e-01 | 0.878 | 1 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.351669e-01 | 0.869 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.903665e-01 | 0.720 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.903665e-01 | 0.720 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 1.903665e-01 | 0.720 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.903665e-01 | 0.720 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.238552e-01 | 0.650 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.238552e-01 | 0.650 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.238552e-01 | 0.650 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.238552e-01 | 0.650 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.238552e-01 | 0.650 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 2.238552e-01 | 0.650 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.559607e-01 | 0.592 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.559607e-01 | 0.592 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.559607e-01 | 0.592 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.559607e-01 | 0.592 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.867399e-01 | 0.543 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.867399e-01 | 0.543 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.867399e-01 | 0.543 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.867399e-01 | 0.543 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.867399e-01 | 0.543 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.867399e-01 | 0.543 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.867399e-01 | 0.543 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.867399e-01 | 0.543 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.619907e-01 | 0.791 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.768973e-01 | 0.752 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.768973e-01 | 0.752 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.162478e-01 | 0.500 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.162478e-01 | 0.500 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.920054e-01 | 0.717 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.920054e-01 | 0.717 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.920054e-01 | 0.717 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.920054e-01 | 0.717 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.072730e-01 | 0.683 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 2.072730e-01 | 0.683 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.226611e-01 | 0.652 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.226611e-01 | 0.652 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.226611e-01 | 0.652 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 2.226611e-01 | 0.652 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.226611e-01 | 0.652 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.647906e-01 | 0.783 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.381337e-01 | 0.623 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.381337e-01 | 0.623 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.855060e-01 | 0.732 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.855060e-01 | 0.732 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.961082e-01 | 0.708 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.961082e-01 | 0.708 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.068537e-01 | 0.684 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.068537e-01 | 0.684 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.847390e-01 | 0.546 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.177280e-01 | 0.662 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.287171e-01 | 0.641 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.002424e-01 | 0.523 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.156885e-01 | 0.501 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.156885e-01 | 0.501 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.509846e-01 | 0.600 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.622365e-01 | 0.581 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.735501e-01 | 0.563 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.849132e-01 | 0.545 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.849132e-01 | 0.545 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.494613e-01 | 0.603 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.494613e-01 | 0.603 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.585937e-01 | 0.587 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.145050e-01 | 0.502 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.145050e-01 | 0.502 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.908443e-01 | 0.536 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.043680e-01 | 0.690 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.622365e-01 | 0.581 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.855060e-01 | 0.732 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.961082e-01 | 0.708 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.002424e-01 | 0.523 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.002424e-01 | 0.523 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.622365e-01 | 0.581 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.381337e-01 | 0.623 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.381337e-01 | 0.623 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.735501e-01 | 0.563 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.077406e-01 | 0.512 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.959648e-01 | 0.708 | 1 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.314183e-01 | 0.636 | 1 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.536576e-01 | 0.596 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.847390e-01 | 0.546 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.536576e-01 | 0.596 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.559607e-01 | 0.592 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.191825e-01 | 0.496 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.226611e-01 | 0.652 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.226611e-01 | 0.652 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.225543e-01 | 0.653 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.225543e-01 | 0.653 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.713493e-01 | 0.766 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.806384e-01 | 0.552 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.879383e-01 | 0.726 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.619907e-01 | 0.791 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.162478e-01 | 0.500 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.920054e-01 | 0.717 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.961082e-01 | 0.708 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.632558e-01 | 0.787 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.052826e-01 | 0.515 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.404005e-01 | 0.619 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.920054e-01 | 0.717 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.849132e-01 | 0.545 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.191825e-01 | 0.496 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.648150e-01 | 0.783 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.700764e-01 | 0.769 | 1 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.536576e-01 | 0.596 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.632455e-01 | 0.787 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.713493e-01 | 0.766 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.957000e-01 | 0.529 | 1 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.749641e-01 | 0.757 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.072730e-01 | 0.683 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.855060e-01 | 0.732 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.287171e-01 | 0.641 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.912082e-01 | 0.718 | 1 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.903665e-01 | 0.720 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.867399e-01 | 0.543 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.867399e-01 | 0.543 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 2.867399e-01 | 0.543 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.867399e-01 | 0.543 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.867399e-01 | 0.543 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.867399e-01 | 0.543 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.768973e-01 | 0.752 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.647906e-01 | 0.783 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.849132e-01 | 0.545 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.191825e-01 | 0.496 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.672750e-01 | 0.573 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.834320e-01 | 0.737 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.472154e-01 | 0.607 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.855159e-01 | 0.544 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.536576e-01 | 0.596 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.619907e-01 | 0.791 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.847390e-01 | 0.546 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.622365e-01 | 0.581 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.072730e-01 | 0.683 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.715243e-01 | 0.566 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.263333e-01 | 0.645 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.855523e-01 | 0.544 | 1 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.398071e-01 | 0.620 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.404005e-01 | 0.619 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 1.852640e-01 | 0.732 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.735501e-01 | 0.563 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.768973e-01 | 0.752 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.436992e-01 | 0.613 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.436992e-01 | 0.613 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.692021e-01 | 0.570 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.855060e-01 | 0.732 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.988254e-01 | 0.702 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.848947e-01 | 0.733 | 1 | 1 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.840619e-01 | 0.735 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.840619e-01 | 0.735 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.775970e-01 | 0.557 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.559607e-01 | 0.592 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.867399e-01 | 0.543 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.381337e-01 | 0.623 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.287171e-01 | 0.641 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.879383e-01 | 0.726 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.225219e-01 | 0.653 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.964194e-01 | 0.707 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.867399e-01 | 0.543 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.622365e-01 | 0.581 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.145017e-01 | 0.502 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.034492e-01 | 0.692 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.903665e-01 | 0.720 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.162478e-01 | 0.500 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.287171e-01 | 0.641 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.509846e-01 | 0.600 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.207182e-01 | 0.656 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.963139e-01 | 0.528 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.226611e-01 | 0.652 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.961629e-01 | 0.528 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.961629e-01 | 0.528 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.783825e-01 | 0.749 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.920054e-01 | 0.717 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.081458e-01 | 0.511 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.177280e-01 | 0.662 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.903665e-01 | 0.720 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.559607e-01 | 0.592 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.867399e-01 | 0.543 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.162478e-01 | 0.500 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.156885e-01 | 0.501 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.191825e-01 | 0.496 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.191825e-01 | 0.496 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.672750e-01 | 0.573 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.795792e-01 | 0.746 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.795792e-01 | 0.746 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.075665e-01 | 0.512 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.920054e-01 | 0.717 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.607588e-01 | 0.584 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.287171e-01 | 0.641 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.156885e-01 | 0.501 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.559607e-01 | 0.592 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.867399e-01 | 0.543 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.619907e-01 | 0.791 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.162478e-01 | 0.500 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.162478e-01 | 0.500 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.226611e-01 | 0.652 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 2.509846e-01 | 0.600 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.963139e-01 | 0.528 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.539860e-01 | 0.595 | 1 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.501931e-01 | 0.602 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.879383e-01 | 0.726 | 1 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.694556e-01 | 0.771 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.920054e-01 | 0.717 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.847390e-01 | 0.546 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.287171e-01 | 0.641 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.867399e-01 | 0.543 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.398071e-01 | 0.620 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.077406e-01 | 0.512 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.514976e-01 | 0.599 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.296313e-01 | 0.639 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.735501e-01 | 0.563 | 1 | 1 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.187320e-01 | 0.497 | 1 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.162478e-01 | 0.500 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.647906e-01 | 0.783 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.536576e-01 | 0.596 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.287171e-01 | 0.641 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.156885e-01 | 0.501 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.920013e-01 | 0.717 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.536576e-01 | 0.596 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 2.398071e-01 | 0.620 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.863505e-01 | 0.543 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 3.145050e-01 | 0.502 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.735501e-01 | 0.563 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.768973e-01 | 0.752 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.381337e-01 | 0.623 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.156885e-01 | 0.501 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.536576e-01 | 0.596 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.509846e-01 | 0.600 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.409704e-01 | 0.618 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.211572e-01 | 0.493 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.211572e-01 | 0.493 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.231575e-01 | 0.491 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.239318e-01 | 0.490 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.239478e-01 | 0.490 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.239478e-01 | 0.490 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.253676e-01 | 0.488 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.306288e-01 | 0.481 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.306288e-01 | 0.481 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.310557e-01 | 0.480 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.310557e-01 | 0.480 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.334092e-01 | 0.477 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.334092e-01 | 0.477 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.334092e-01 | 0.477 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.387101e-01 | 0.470 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.399435e-01 | 0.469 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.420695e-01 | 0.466 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.420695e-01 | 0.466 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.420695e-01 | 0.466 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.428830e-01 | 0.465 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.428830e-01 | 0.465 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.439243e-01 | 0.464 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.445365e-01 | 0.463 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.445365e-01 | 0.463 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.445365e-01 | 0.463 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.445365e-01 | 0.463 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.445365e-01 | 0.463 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 3.445365e-01 | 0.463 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.445365e-01 | 0.463 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.445365e-01 | 0.463 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.445365e-01 | 0.463 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.445365e-01 | 0.463 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.445365e-01 | 0.463 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.445365e-01 | 0.463 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.445365e-01 | 0.463 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.461993e-01 | 0.461 | 1 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.463239e-01 | 0.461 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.463239e-01 | 0.461 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.486417e-01 | 0.458 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.505830e-01 | 0.455 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.534947e-01 | 0.452 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.559812e-01 | 0.449 | 1 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.569054e-01 | 0.447 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.591014e-01 | 0.445 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.614752e-01 | 0.442 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.614752e-01 | 0.442 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.614752e-01 | 0.442 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 3.614752e-01 | 0.442 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.648747e-01 | 0.438 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.648951e-01 | 0.438 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.709652e-01 | 0.431 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.713211e-01 | 0.430 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.716566e-01 | 0.430 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.716566e-01 | 0.430 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.716566e-01 | 0.430 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.716566e-01 | 0.430 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.716566e-01 | 0.430 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.716566e-01 | 0.430 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.716566e-01 | 0.430 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.716566e-01 | 0.430 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.716566e-01 | 0.430 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.716566e-01 | 0.430 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.762619e-01 | 0.425 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.762619e-01 | 0.425 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.764932e-01 | 0.424 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 3.764932e-01 | 0.424 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 3.764932e-01 | 0.424 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 3.764932e-01 | 0.424 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.764932e-01 | 0.424 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.764932e-01 | 0.424 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.794932e-01 | 0.421 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.794932e-01 | 0.421 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.794932e-01 | 0.421 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.794932e-01 | 0.421 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.838985e-01 | 0.416 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.855485e-01 | 0.414 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.875865e-01 | 0.412 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 3.875865e-01 | 0.412 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.884680e-01 | 0.411 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.884680e-01 | 0.411 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.913628e-01 | 0.407 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.913628e-01 | 0.407 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.913628e-01 | 0.407 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.913628e-01 | 0.407 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.913628e-01 | 0.407 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.913628e-01 | 0.407 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.921746e-01 | 0.407 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.976561e-01 | 0.400 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.976561e-01 | 0.400 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.976561e-01 | 0.400 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.976561e-01 | 0.400 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.976561e-01 | 0.400 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.976561e-01 | 0.400 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.976561e-01 | 0.400 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.976561e-01 | 0.400 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.976561e-01 | 0.400 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.988609e-01 | 0.399 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.996688e-01 | 0.398 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.060708e-01 | 0.391 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.060708e-01 | 0.391 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.060708e-01 | 0.391 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.060708e-01 | 0.391 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.060708e-01 | 0.391 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.060708e-01 | 0.391 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.065050e-01 | 0.391 | 1 | 1 |
| Gastrulation | R-HSA-9758941 | 4.090882e-01 | 0.388 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.100775e-01 | 0.387 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.107617e-01 | 0.386 | 1 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.206051e-01 | 0.376 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.206051e-01 | 0.376 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.206051e-01 | 0.376 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.206051e-01 | 0.376 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.225814e-01 | 0.374 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.225814e-01 | 0.374 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.225814e-01 | 0.374 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.225814e-01 | 0.374 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.225814e-01 | 0.374 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.225814e-01 | 0.374 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.225814e-01 | 0.374 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.225814e-01 | 0.374 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.225814e-01 | 0.374 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.225814e-01 | 0.374 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.277882e-01 | 0.369 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.311554e-01 | 0.365 | 1 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.329763e-01 | 0.364 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.349549e-01 | 0.362 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.349549e-01 | 0.362 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.349549e-01 | 0.362 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.349549e-01 | 0.362 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.403521e-01 | 0.356 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.464766e-01 | 0.350 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.464766e-01 | 0.350 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 4.464766e-01 | 0.350 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 4.464766e-01 | 0.350 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.464766e-01 | 0.350 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.464766e-01 | 0.350 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 4.464766e-01 | 0.350 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.464766e-01 | 0.350 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.474729e-01 | 0.349 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.491106e-01 | 0.348 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.491106e-01 | 0.348 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.491106e-01 | 0.348 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.630636e-01 | 0.334 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.630636e-01 | 0.334 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.650529e-01 | 0.332 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.650529e-01 | 0.332 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.650529e-01 | 0.332 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.693845e-01 | 0.328 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.693845e-01 | 0.328 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.693845e-01 | 0.328 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.693845e-01 | 0.328 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.693845e-01 | 0.328 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.693845e-01 | 0.328 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.693845e-01 | 0.328 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.693845e-01 | 0.328 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.693845e-01 | 0.328 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.738163e-01 | 0.324 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.757838e-01 | 0.323 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.757838e-01 | 0.323 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.768066e-01 | 0.322 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.769100e-01 | 0.322 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.797219e-01 | 0.319 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.797219e-01 | 0.319 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.797219e-01 | 0.319 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.876877e-01 | 0.312 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.903330e-01 | 0.310 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.903330e-01 | 0.310 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.903330e-01 | 0.310 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.913456e-01 | 0.309 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.913456e-01 | 0.309 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.913456e-01 | 0.309 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.913456e-01 | 0.309 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.913456e-01 | 0.309 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.913456e-01 | 0.309 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.913456e-01 | 0.309 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.913456e-01 | 0.309 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 4.918419e-01 | 0.308 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.956097e-01 | 0.305 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.969395e-01 | 0.304 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.036373e-01 | 0.298 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.036373e-01 | 0.298 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.036373e-01 | 0.298 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 5.036373e-01 | 0.298 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.045469e-01 | 0.297 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.056444e-01 | 0.296 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.073552e-01 | 0.295 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.073552e-01 | 0.295 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.073552e-01 | 0.295 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.073552e-01 | 0.295 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.096057e-01 | 0.293 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.123990e-01 | 0.290 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.123990e-01 | 0.290 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.123990e-01 | 0.290 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.123990e-01 | 0.290 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.123990e-01 | 0.290 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.123990e-01 | 0.290 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.123990e-01 | 0.290 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.123990e-01 | 0.290 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.123990e-01 | 0.290 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.123990e-01 | 0.290 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.123990e-01 | 0.290 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.123990e-01 | 0.290 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 5.123990e-01 | 0.290 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.123990e-01 | 0.290 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.123990e-01 | 0.290 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.123990e-01 | 0.290 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.167146e-01 | 0.287 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.167146e-01 | 0.287 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.167146e-01 | 0.287 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.167146e-01 | 0.287 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.167146e-01 | 0.287 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.167146e-01 | 0.287 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.167146e-01 | 0.287 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.190898e-01 | 0.285 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.205041e-01 | 0.284 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.325823e-01 | 0.274 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.325823e-01 | 0.274 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.325823e-01 | 0.274 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.325823e-01 | 0.274 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.325823e-01 | 0.274 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.325823e-01 | 0.274 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.325823e-01 | 0.274 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 5.325823e-01 | 0.274 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.325823e-01 | 0.274 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.339981e-01 | 0.272 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.344828e-01 | 0.272 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.357082e-01 | 0.271 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.379068e-01 | 0.269 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.391203e-01 | 0.268 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 5.395823e-01 | 0.268 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.398313e-01 | 0.268 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.407438e-01 | 0.267 | 1 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.421731e-01 | 0.266 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.421731e-01 | 0.266 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.519313e-01 | 0.258 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.519313e-01 | 0.258 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.519313e-01 | 0.258 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.519313e-01 | 0.258 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.519313e-01 | 0.258 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.519313e-01 | 0.258 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.519313e-01 | 0.258 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.519313e-01 | 0.258 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.519313e-01 | 0.258 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.519313e-01 | 0.258 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 5.519313e-01 | 0.258 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.519313e-01 | 0.258 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.519313e-01 | 0.258 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.519313e-01 | 0.258 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.519313e-01 | 0.258 | 1 | 1 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.527171e-01 | 0.257 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.544512e-01 | 0.256 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.544512e-01 | 0.256 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.545484e-01 | 0.256 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.576617e-01 | 0.254 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.576617e-01 | 0.254 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.610968e-01 | 0.251 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.650914e-01 | 0.248 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.666848e-01 | 0.247 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.666848e-01 | 0.247 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.673469e-01 | 0.246 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.673469e-01 | 0.246 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.673469e-01 | 0.246 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.673469e-01 | 0.246 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.673469e-01 | 0.246 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.704805e-01 | 0.244 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.704805e-01 | 0.244 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.704805e-01 | 0.244 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.704805e-01 | 0.244 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.704805e-01 | 0.244 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.704805e-01 | 0.244 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.704805e-01 | 0.244 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.704805e-01 | 0.244 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.704805e-01 | 0.244 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.775965e-01 | 0.238 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.863213e-01 | 0.232 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.879113e-01 | 0.231 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.882628e-01 | 0.230 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.882628e-01 | 0.230 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.882628e-01 | 0.230 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.882628e-01 | 0.230 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.882628e-01 | 0.230 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.883701e-01 | 0.230 | 1 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.902359e-01 | 0.229 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.902359e-01 | 0.229 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.902359e-01 | 0.229 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.902359e-01 | 0.229 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.902359e-01 | 0.229 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 5.937875e-01 | 0.226 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.956066e-01 | 0.225 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.007422e-01 | 0.221 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.016493e-01 | 0.221 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.016493e-01 | 0.221 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.016701e-01 | 0.221 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.053100e-01 | 0.218 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.053100e-01 | 0.218 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.053100e-01 | 0.218 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.053100e-01 | 0.218 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.053100e-01 | 0.218 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.053100e-01 | 0.218 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.053100e-01 | 0.218 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.053100e-01 | 0.218 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.095083e-01 | 0.215 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.128211e-01 | 0.213 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.137658e-01 | 0.212 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.216524e-01 | 0.206 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.216524e-01 | 0.206 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.216524e-01 | 0.206 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.216524e-01 | 0.206 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.216524e-01 | 0.206 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.216524e-01 | 0.206 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.216524e-01 | 0.206 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.216524e-01 | 0.206 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.216524e-01 | 0.206 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.216524e-01 | 0.206 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.216524e-01 | 0.206 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.216524e-01 | 0.206 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.237517e-01 | 0.205 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.237517e-01 | 0.205 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.237517e-01 | 0.205 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.237517e-01 | 0.205 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.237517e-01 | 0.205 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.248974e-01 | 0.204 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.284178e-01 | 0.202 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.344419e-01 | 0.198 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.373190e-01 | 0.196 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.373190e-01 | 0.196 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.373190e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.373190e-01 | 0.196 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.373190e-01 | 0.196 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.373190e-01 | 0.196 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.373190e-01 | 0.196 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.373190e-01 | 0.196 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.373190e-01 | 0.196 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.373190e-01 | 0.196 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.373190e-01 | 0.196 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.373190e-01 | 0.196 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.373190e-01 | 0.196 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.373190e-01 | 0.196 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.399585e-01 | 0.194 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.399585e-01 | 0.194 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.399585e-01 | 0.194 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.448930e-01 | 0.191 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.448930e-01 | 0.191 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.448930e-01 | 0.191 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.453856e-01 | 0.190 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.484073e-01 | 0.188 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.523379e-01 | 0.186 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.523379e-01 | 0.186 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.523379e-01 | 0.186 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.523379e-01 | 0.186 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.523379e-01 | 0.186 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.523379e-01 | 0.186 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.523379e-01 | 0.186 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.523379e-01 | 0.186 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.523379e-01 | 0.186 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.523379e-01 | 0.186 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.523379e-01 | 0.186 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.523379e-01 | 0.186 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.551064e-01 | 0.184 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.551064e-01 | 0.184 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.616499e-01 | 0.179 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.616499e-01 | 0.179 | 1 | 1 |
| SLC transporter disorders | R-HSA-5619102 | 6.644944e-01 | 0.178 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.650839e-01 | 0.177 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.667357e-01 | 0.176 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.667357e-01 | 0.176 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.667357e-01 | 0.176 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.667357e-01 | 0.176 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.667357e-01 | 0.176 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.667357e-01 | 0.176 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.667357e-01 | 0.176 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.667357e-01 | 0.176 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.667357e-01 | 0.176 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.729019e-01 | 0.172 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.729019e-01 | 0.172 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.770282e-01 | 0.169 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.789399e-01 | 0.168 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.805381e-01 | 0.167 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.805381e-01 | 0.167 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.805381e-01 | 0.167 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.805381e-01 | 0.167 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.805381e-01 | 0.167 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.805381e-01 | 0.167 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.805381e-01 | 0.167 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.805381e-01 | 0.167 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.805381e-01 | 0.167 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.805381e-01 | 0.167 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.807826e-01 | 0.167 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.807826e-01 | 0.167 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.807826e-01 | 0.167 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.843392e-01 | 0.165 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.885215e-01 | 0.162 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.892397e-01 | 0.162 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.905248e-01 | 0.161 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.923019e-01 | 0.160 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.923019e-01 | 0.160 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.936218e-01 | 0.159 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.937696e-01 | 0.159 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.937696e-01 | 0.159 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.937696e-01 | 0.159 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.937696e-01 | 0.159 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.937696e-01 | 0.159 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.937696e-01 | 0.159 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.961188e-01 | 0.157 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.026779e-01 | 0.153 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.035752e-01 | 0.153 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.035752e-01 | 0.153 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.064539e-01 | 0.151 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.064539e-01 | 0.151 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.099300e-01 | 0.149 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.115102e-01 | 0.148 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.115102e-01 | 0.148 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.140419e-01 | 0.146 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.180674e-01 | 0.144 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.186135e-01 | 0.144 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.186135e-01 | 0.144 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.186135e-01 | 0.144 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.186135e-01 | 0.144 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.186135e-01 | 0.144 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.201219e-01 | 0.143 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.201219e-01 | 0.143 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.251047e-01 | 0.140 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.251047e-01 | 0.140 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.285159e-01 | 0.138 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.285159e-01 | 0.138 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.285159e-01 | 0.138 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.285159e-01 | 0.138 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.288788e-01 | 0.137 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.302702e-01 | 0.137 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.302702e-01 | 0.137 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.302702e-01 | 0.137 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.302702e-01 | 0.137 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.302702e-01 | 0.137 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.302702e-01 | 0.137 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 7.302702e-01 | 0.137 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.302702e-01 | 0.137 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.366955e-01 | 0.133 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.376908e-01 | 0.132 | 1 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.387665e-01 | 0.131 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.414446e-01 | 0.130 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.414446e-01 | 0.130 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.414446e-01 | 0.130 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.446642e-01 | 0.128 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.453929e-01 | 0.128 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.477835e-01 | 0.126 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.510918e-01 | 0.124 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.521568e-01 | 0.124 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.521568e-01 | 0.124 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.521568e-01 | 0.124 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.521568e-01 | 0.124 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.521568e-01 | 0.124 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.521568e-01 | 0.124 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.521568e-01 | 0.124 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.524253e-01 | 0.124 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.524253e-01 | 0.124 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.555762e-01 | 0.122 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.572577e-01 | 0.121 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.599823e-01 | 0.119 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.599823e-01 | 0.119 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.624258e-01 | 0.118 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.624258e-01 | 0.118 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.624258e-01 | 0.118 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.624258e-01 | 0.118 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.624258e-01 | 0.118 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.624258e-01 | 0.118 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.624258e-01 | 0.118 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.624258e-01 | 0.118 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.624258e-01 | 0.118 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.624258e-01 | 0.118 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.673388e-01 | 0.115 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.722699e-01 | 0.112 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 7.722699e-01 | 0.112 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.722699e-01 | 0.112 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.722699e-01 | 0.112 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.722699e-01 | 0.112 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.722699e-01 | 0.112 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.722699e-01 | 0.112 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.732565e-01 | 0.112 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.744984e-01 | 0.111 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.746215e-01 | 0.111 | 1 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.814649e-01 | 0.107 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.814649e-01 | 0.107 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.814649e-01 | 0.107 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.815149e-01 | 0.107 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.817066e-01 | 0.107 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.817066e-01 | 0.107 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.817066e-01 | 0.107 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.817066e-01 | 0.107 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.873189e-01 | 0.104 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.880791e-01 | 0.103 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.907529e-01 | 0.102 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.907529e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.907529e-01 | 0.102 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 7.907529e-01 | 0.102 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.907529e-01 | 0.102 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.907529e-01 | 0.102 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.934135e-01 | 0.101 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.948331e-01 | 0.100 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.994248e-01 | 0.097 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.994248e-01 | 0.097 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.994248e-01 | 0.097 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.994248e-01 | 0.097 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.012423e-01 | 0.096 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.044709e-01 | 0.094 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.050033e-01 | 0.094 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.077379e-01 | 0.093 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.077379e-01 | 0.093 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.077379e-01 | 0.093 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.077379e-01 | 0.093 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.077379e-01 | 0.093 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.096928e-01 | 0.092 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.147965e-01 | 0.089 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.157069e-01 | 0.088 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.157069e-01 | 0.088 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.157069e-01 | 0.088 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.157069e-01 | 0.088 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.194155e-01 | 0.086 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.233460e-01 | 0.084 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.233460e-01 | 0.084 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.233460e-01 | 0.084 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.233460e-01 | 0.084 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.233460e-01 | 0.084 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.237650e-01 | 0.084 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.251343e-01 | 0.083 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.294159e-01 | 0.081 | 1 | 1 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.306689e-01 | 0.081 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.306689e-01 | 0.081 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.306689e-01 | 0.081 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.306689e-01 | 0.081 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.306689e-01 | 0.081 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 8.306689e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.360856e-01 | 0.078 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.376887e-01 | 0.077 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.376887e-01 | 0.077 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.376887e-01 | 0.077 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.376887e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.376887e-01 | 0.077 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.376887e-01 | 0.077 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.413256e-01 | 0.075 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.444179e-01 | 0.073 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.444179e-01 | 0.073 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.444179e-01 | 0.073 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 8.444179e-01 | 0.073 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.464134e-01 | 0.072 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.476543e-01 | 0.072 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.476543e-01 | 0.072 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.508685e-01 | 0.070 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.513525e-01 | 0.070 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.513525e-01 | 0.070 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.545175e-01 | 0.068 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.557025e-01 | 0.068 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.561465e-01 | 0.067 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.570521e-01 | 0.067 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.570521e-01 | 0.067 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.570521e-01 | 0.067 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.570521e-01 | 0.067 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.570521e-01 | 0.067 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.570521e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.570521e-01 | 0.067 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.607989e-01 | 0.065 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.607989e-01 | 0.065 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.611214e-01 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.629796e-01 | 0.064 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.629796e-01 | 0.064 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.629796e-01 | 0.064 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.629796e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.629796e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.629796e-01 | 0.064 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.629796e-01 | 0.064 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.629796e-01 | 0.064 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.653133e-01 | 0.063 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.675558e-01 | 0.062 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.686617e-01 | 0.061 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.686617e-01 | 0.061 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.686617e-01 | 0.061 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.709074e-01 | 0.060 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.711972e-01 | 0.060 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.741084e-01 | 0.058 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.741084e-01 | 0.058 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.741084e-01 | 0.058 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.748338e-01 | 0.058 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.780624e-01 | 0.056 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.818352e-01 | 0.055 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.820584e-01 | 0.055 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.820584e-01 | 0.055 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 8.820584e-01 | 0.055 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.824711e-01 | 0.054 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.843346e-01 | 0.053 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.885134e-01 | 0.051 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.885134e-01 | 0.051 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.891323e-01 | 0.051 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.891323e-01 | 0.051 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.891323e-01 | 0.051 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 8.891323e-01 | 0.051 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.937312e-01 | 0.049 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.937312e-01 | 0.049 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.937312e-01 | 0.049 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.937312e-01 | 0.049 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.937312e-01 | 0.049 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.937312e-01 | 0.049 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.937312e-01 | 0.049 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.965445e-01 | 0.047 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.981396e-01 | 0.047 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.981396e-01 | 0.047 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.981396e-01 | 0.047 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.981396e-01 | 0.047 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.981396e-01 | 0.047 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.006349e-01 | 0.045 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.064162e-01 | 0.043 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.064162e-01 | 0.043 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.067868e-01 | 0.042 | 1 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.077063e-01 | 0.042 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.077063e-01 | 0.042 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.102992e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.102992e-01 | 0.041 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.106617e-01 | 0.041 | 1 | 1 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.140212e-01 | 0.039 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.175890e-01 | 0.037 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.186789e-01 | 0.037 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.205403e-01 | 0.036 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.210090e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.210090e-01 | 0.036 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.210090e-01 | 0.036 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.242873e-01 | 0.034 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.260879e-01 | 0.033 | 1 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.274297e-01 | 0.033 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.281296e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.304418e-01 | 0.031 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.333291e-01 | 0.030 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.338496e-01 | 0.030 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.361020e-01 | 0.029 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.382815e-01 | 0.028 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.387496e-01 | 0.027 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.387496e-01 | 0.027 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.412926e-01 | 0.026 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.412926e-01 | 0.026 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.437301e-01 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.460665e-01 | 0.024 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.460665e-01 | 0.024 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.463141e-01 | 0.024 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.483060e-01 | 0.023 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.486004e-01 | 0.023 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.490274e-01 | 0.023 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.504527e-01 | 0.022 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.504527e-01 | 0.022 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.525104e-01 | 0.021 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.577453e-01 | 0.019 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.581854e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.581854e-01 | 0.019 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.594910e-01 | 0.018 | 1 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.599224e-01 | 0.018 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.599224e-01 | 0.018 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.601733e-01 | 0.018 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.605139e-01 | 0.017 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.617920e-01 | 0.017 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.631831e-01 | 0.016 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.635963e-01 | 0.016 | 1 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.647128e-01 | 0.016 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.647128e-01 | 0.016 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.647128e-01 | 0.016 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.648569e-01 | 0.016 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.661790e-01 | 0.015 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.672770e-01 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.672770e-01 | 0.014 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.702132e-01 | 0.013 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.702225e-01 | 0.013 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.702225e-01 | 0.013 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.714600e-01 | 0.013 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.726459e-01 | 0.012 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.726462e-01 | 0.012 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.737832e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.737832e-01 | 0.012 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.737832e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.746485e-01 | 0.011 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.759175e-01 | 0.011 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.766338e-01 | 0.010 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.769186e-01 | 0.010 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.770010e-01 | 0.010 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.773533e-01 | 0.010 | 1 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.779719e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.784523e-01 | 0.009 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.791449e-01 | 0.009 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.796796e-01 | 0.009 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.821107e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.821107e-01 | 0.008 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.834608e-01 | 0.007 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.835679e-01 | 0.007 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.835679e-01 | 0.007 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.849065e-01 | 0.007 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.855344e-01 | 0.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.861362e-01 | 0.006 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.864221e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.867130e-01 | 0.006 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.872659e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.872659e-01 | 0.006 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.883036e-01 | 0.005 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.886070e-01 | 0.005 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.887904e-01 | 0.005 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.887904e-01 | 0.005 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.892237e-01 | 0.005 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.894089e-01 | 0.005 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.904973e-01 | 0.004 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.913143e-01 | 0.004 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.920225e-01 | 0.003 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.923547e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.925980e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.926730e-01 | 0.003 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.926730e-01 | 0.003 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.934456e-01 | 0.003 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.935509e-01 | 0.003 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.935509e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.937605e-01 | 0.003 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.938195e-01 | 0.003 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.938195e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.947868e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.957861e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.959617e-01 | 0.002 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.959617e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.961300e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.963951e-01 | 0.002 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.966966e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.977755e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.984583e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.986963e-01 | 0.001 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.987219e-01 | 0.001 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.987219e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.987219e-01 | 0.001 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.987752e-01 | 0.001 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.988140e-01 | 0.001 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.989232e-01 | 0.000 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.992006e-01 | 0.000 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.994318e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.995514e-01 | 0.000 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.997131e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997955e-01 | 0.000 | 1 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.998028e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998355e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998740e-01 | 0.000 | 1 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999381e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999653e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999750e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999861e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999938e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999959e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999991e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.448042e-13 | 12.611 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.762990e-12 | 11.424 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.289153e-08 | 7.640 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.179114e-08 | 7.144 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.253890e-07 | 6.647 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.016462e-07 | 6.396 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.064890e-07 | 6.391 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.768972e-07 | 6.239 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.516571e-07 | 6.186 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.208535e-06 | 5.918 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.359264e-06 | 5.627 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.494870e-06 | 5.603 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.545849e-06 | 5.450 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.042054e-06 | 5.393 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.710901e-06 | 5.327 | 1 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.248612e-06 | 5.140 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.435115e-05 | 4.843 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.648759e-05 | 4.783 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.182421e-05 | 4.497 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.735055e-05 | 4.325 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.285333e-05 | 4.202 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.400018e-05 | 4.194 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.420312e-05 | 4.130 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.420312e-05 | 4.130 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.244756e-05 | 4.140 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.038372e-05 | 4.044 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.578753e-05 | 4.019 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.756837e-05 | 4.011 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.006262e-04 | 3.997 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.904402e-05 | 4.004 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.206695e-04 | 3.918 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.532980e-04 | 3.814 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.727077e-04 | 3.763 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.053986e-04 | 3.687 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.053986e-04 | 3.687 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.361136e-04 | 3.627 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.866118e-04 | 3.543 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.841814e-04 | 3.546 | 1 | 1 |
| Membrane Trafficking | R-HSA-199991 | 2.906671e-04 | 3.537 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.841214e-04 | 3.546 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.766540e-04 | 3.558 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.018877e-04 | 3.520 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.018877e-04 | 3.520 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.337248e-04 | 3.477 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.728883e-04 | 3.428 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.675017e-04 | 3.435 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.822739e-04 | 3.418 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.338330e-04 | 3.363 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.047248e-04 | 3.297 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.886493e-04 | 3.311 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.675788e-04 | 3.246 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.071473e-04 | 3.217 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.695141e-04 | 3.174 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.067290e-04 | 3.151 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.711144e-04 | 3.173 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.227806e-04 | 3.141 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.866274e-04 | 3.104 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.805458e-04 | 3.108 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.805458e-04 | 3.108 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.527908e-04 | 3.123 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.254677e-04 | 3.083 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 8.254677e-04 | 3.083 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.804952e-04 | 3.055 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.711826e-04 | 3.060 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.445863e-04 | 3.025 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.458866e-04 | 3.024 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.003647e-03 | 2.998 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.057209e-03 | 2.976 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.073509e-03 | 2.969 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.092002e-03 | 2.962 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.175521e-03 | 2.930 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.175743e-03 | 2.930 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.275114e-03 | 2.894 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.581517e-03 | 2.801 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.687435e-03 | 2.773 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.683348e-03 | 2.774 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.687435e-03 | 2.773 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.763052e-03 | 2.754 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.789300e-03 | 2.747 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.906158e-03 | 2.720 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.906158e-03 | 2.720 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.876287e-03 | 2.727 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.819404e-03 | 2.740 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.906246e-03 | 2.720 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.942566e-03 | 2.712 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.182647e-03 | 2.661 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.264865e-03 | 2.645 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.264865e-03 | 2.645 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.341071e-03 | 2.631 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.479442e-03 | 2.606 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.480984e-03 | 2.605 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.817463e-03 | 2.550 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.112504e-03 | 2.507 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.112504e-03 | 2.507 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.112504e-03 | 2.507 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.112504e-03 | 2.507 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.112504e-03 | 2.507 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.112504e-03 | 2.507 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.260618e-03 | 2.487 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.304138e-03 | 2.481 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.497392e-03 | 2.456 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.319799e-03 | 2.479 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.432550e-03 | 2.464 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.523398e-03 | 2.453 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.361144e-03 | 2.474 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.304138e-03 | 2.481 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.544578e-03 | 2.450 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.544578e-03 | 2.450 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.734768e-03 | 2.428 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.894702e-03 | 2.410 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.037228e-03 | 2.394 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.326687e-03 | 2.364 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.262432e-03 | 2.370 | 1 | 1 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.509648e-03 | 2.346 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.383693e-03 | 2.358 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.704380e-03 | 2.327 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.944683e-03 | 2.306 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.944683e-03 | 2.306 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.027174e-03 | 2.299 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.052500e-03 | 2.296 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.113484e-03 | 2.214 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.628495e-03 | 2.250 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.628495e-03 | 2.250 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.699276e-03 | 2.244 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.488858e-03 | 2.261 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.113484e-03 | 2.214 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.883567e-03 | 2.230 | 1 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.349777e-03 | 2.197 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.349777e-03 | 2.197 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 6.626600e-03 | 2.179 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.866070e-03 | 2.163 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.241428e-03 | 2.140 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.110952e-03 | 2.148 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.110952e-03 | 2.148 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.110952e-03 | 2.148 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.489455e-03 | 2.126 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.318877e-03 | 2.136 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.566679e-03 | 2.121 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.110952e-03 | 2.148 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.566679e-03 | 2.121 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.488415e-03 | 2.126 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.622548e-03 | 2.118 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.657569e-03 | 2.116 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.657569e-03 | 2.116 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.657569e-03 | 2.116 | 1 | 1 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.814362e-03 | 2.107 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.814362e-03 | 2.107 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.614541e-03 | 2.065 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.814362e-03 | 2.107 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.814362e-03 | 2.107 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.672544e-03 | 2.062 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.116125e-03 | 2.040 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.006360e-02 | 1.997 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.006360e-02 | 1.997 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.006360e-02 | 1.997 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.006360e-02 | 1.997 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.858432e-03 | 2.006 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.272797e-03 | 2.033 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.543932e-03 | 2.020 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.543932e-03 | 2.020 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.028303e-02 | 1.988 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.694312e-03 | 2.013 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.543932e-03 | 2.020 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.006360e-02 | 1.997 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.019259e-02 | 1.992 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.988895e-03 | 2.000 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.988895e-03 | 2.000 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.408980e-03 | 2.026 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.107933e-02 | 1.955 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.107933e-02 | 1.955 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.117564e-02 | 1.952 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.117564e-02 | 1.952 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.119254e-02 | 1.951 | 1 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.226967e-02 | 1.911 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.255574e-02 | 1.901 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.255574e-02 | 1.901 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.309333e-02 | 1.883 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.361256e-02 | 1.866 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.388124e-02 | 1.858 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.453844e-02 | 1.837 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.444273e-02 | 1.840 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.278092e-02 | 1.893 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.374742e-02 | 1.862 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.301594e-02 | 1.886 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.275399e-02 | 1.894 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.309333e-02 | 1.883 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.495064e-02 | 1.825 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.495064e-02 | 1.825 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.515497e-02 | 1.819 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.564941e-02 | 1.806 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.576664e-02 | 1.802 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.654548e-02 | 1.781 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.669255e-02 | 1.777 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.669255e-02 | 1.777 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.669255e-02 | 1.777 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.696804e-02 | 1.770 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.702463e-02 | 1.769 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.711570e-02 | 1.767 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.755325e-02 | 1.756 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.755325e-02 | 1.756 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.771672e-02 | 1.752 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.837503e-02 | 1.736 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.873083e-02 | 1.727 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.934318e-02 | 1.713 | 1 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.954220e-02 | 1.709 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.957778e-02 | 1.708 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.031044e-02 | 1.692 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.324465e-02 | 1.634 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.150984e-02 | 1.667 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.002475e-02 | 1.698 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.998421e-02 | 1.699 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.251673e-02 | 1.647 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.031044e-02 | 1.692 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.235166e-02 | 1.651 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.046474e-02 | 1.689 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.999541e-02 | 1.699 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.324465e-02 | 1.634 | 1 | 1 |
| Regulation of beta-cell development | R-HSA-186712 | 2.228660e-02 | 1.652 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.328927e-02 | 1.633 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.328927e-02 | 1.633 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.365947e-02 | 1.626 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.365947e-02 | 1.626 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.386073e-02 | 1.622 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.392968e-02 | 1.621 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.392968e-02 | 1.621 | 1 | 1 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.392968e-02 | 1.621 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.392968e-02 | 1.621 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.392968e-02 | 1.621 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.392968e-02 | 1.621 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.433007e-02 | 1.614 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.446547e-02 | 1.611 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.515614e-02 | 1.599 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.549812e-02 | 1.593 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.575869e-02 | 1.589 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.580350e-02 | 1.588 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.673287e-02 | 1.573 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.673840e-02 | 1.573 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.685682e-02 | 1.571 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.685682e-02 | 1.571 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.685682e-02 | 1.571 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.719494e-02 | 1.566 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.719494e-02 | 1.566 | 1 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.097955e-02 | 1.509 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.097955e-02 | 1.509 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.948705e-02 | 1.530 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.277662e-02 | 1.484 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.277662e-02 | 1.484 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.277662e-02 | 1.484 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.277662e-02 | 1.484 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.277662e-02 | 1.484 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.150633e-02 | 1.502 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.013803e-02 | 1.521 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.053702e-02 | 1.515 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.942649e-02 | 1.531 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.097951e-02 | 1.509 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.914908e-02 | 1.535 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.810191e-02 | 1.551 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.182074e-02 | 1.497 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.783823e-02 | 1.555 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.058373e-02 | 1.515 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.957099e-02 | 1.529 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.022686e-02 | 1.520 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.948705e-02 | 1.530 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.948705e-02 | 1.530 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 3.097955e-02 | 1.509 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 3.097955e-02 | 1.509 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.292797e-02 | 1.482 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.292797e-02 | 1.482 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.292797e-02 | 1.482 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.292797e-02 | 1.482 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.333529e-02 | 1.477 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.434307e-02 | 1.464 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.471489e-02 | 1.459 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.473126e-02 | 1.459 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.513736e-02 | 1.454 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.513736e-02 | 1.454 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.513736e-02 | 1.454 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.513736e-02 | 1.454 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.513736e-02 | 1.454 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.513736e-02 | 1.454 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.513736e-02 | 1.454 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.540617e-02 | 1.451 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.573901e-02 | 1.447 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.607376e-02 | 1.443 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.607376e-02 | 1.443 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.618699e-02 | 1.441 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.677057e-02 | 1.434 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.677057e-02 | 1.434 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.677057e-02 | 1.434 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.782611e-02 | 1.422 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.439852e-02 | 1.353 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.067042e-02 | 1.391 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.067042e-02 | 1.391 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.067042e-02 | 1.391 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.968896e-02 | 1.401 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.968896e-02 | 1.401 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.110787e-02 | 1.386 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.110787e-02 | 1.386 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.572034e-02 | 1.340 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.110787e-02 | 1.386 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.186902e-02 | 1.378 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.378253e-02 | 1.359 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.142285e-02 | 1.383 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.272449e-02 | 1.369 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.172836e-02 | 1.380 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.399011e-02 | 1.357 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.928979e-02 | 1.406 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.439852e-02 | 1.353 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.378253e-02 | 1.359 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.167213e-02 | 1.380 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.610598e-02 | 1.336 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.961338e-02 | 1.402 | 1 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.067042e-02 | 1.391 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.626852e-02 | 1.335 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.525262e-02 | 1.344 | 1 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.751006e-02 | 1.323 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.796677e-02 | 1.319 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.848408e-02 | 1.314 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.853515e-02 | 1.314 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.894211e-02 | 1.310 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.963994e-02 | 1.304 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.990668e-02 | 1.302 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.078915e-02 | 1.294 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.089535e-02 | 1.293 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.093540e-02 | 1.293 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.093540e-02 | 1.293 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.093540e-02 | 1.293 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.134061e-02 | 1.290 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.156659e-02 | 1.288 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.330159e-02 | 1.273 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.330159e-02 | 1.273 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.351648e-02 | 1.272 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.378217e-02 | 1.269 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.466060e-02 | 1.262 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.466060e-02 | 1.262 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.466060e-02 | 1.262 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.466060e-02 | 1.262 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.480935e-02 | 1.261 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.489224e-02 | 1.260 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.595659e-02 | 1.252 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.622910e-02 | 1.250 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.627158e-02 | 1.250 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.627158e-02 | 1.250 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.654511e-02 | 1.248 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.654511e-02 | 1.248 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.654511e-02 | 1.248 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.783118e-02 | 1.238 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.790478e-02 | 1.237 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.790478e-02 | 1.237 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.886816e-02 | 1.230 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.886816e-02 | 1.230 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.886816e-02 | 1.230 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.017154e-02 | 1.221 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.058763e-02 | 1.218 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.058763e-02 | 1.218 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.131180e-02 | 1.212 | 1 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.187024e-02 | 1.209 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.202572e-02 | 1.207 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.264913e-02 | 1.203 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.264913e-02 | 1.203 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.264913e-02 | 1.203 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.264913e-02 | 1.203 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 7.195207e-02 | 1.143 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 7.195207e-02 | 1.143 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.947842e-02 | 1.100 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.122510e-02 | 1.147 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.582216e-02 | 1.120 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.582216e-02 | 1.120 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.717935e-02 | 1.112 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.717935e-02 | 1.112 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.669686e-02 | 1.115 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.513603e-02 | 1.124 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.408638e-02 | 1.193 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.474749e-02 | 1.189 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.528264e-02 | 1.185 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.313318e-02 | 1.136 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.323515e-02 | 1.199 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.998537e-02 | 1.097 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.500021e-02 | 1.187 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.721240e-02 | 1.112 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.721240e-02 | 1.112 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.252062e-02 | 1.083 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.252062e-02 | 1.083 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 7.582216e-02 | 1.120 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.235848e-02 | 1.084 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.533353e-02 | 1.185 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.473011e-02 | 1.127 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.998537e-02 | 1.097 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.998537e-02 | 1.097 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.195207e-02 | 1.143 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.582216e-02 | 1.120 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.232456e-02 | 1.141 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.998537e-02 | 1.097 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.533353e-02 | 1.185 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.760506e-02 | 1.170 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.529624e-02 | 1.185 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.252062e-02 | 1.083 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.252062e-02 | 1.083 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.947842e-02 | 1.100 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.910600e-02 | 1.102 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.420029e-02 | 1.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.252062e-02 | 1.083 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 7.947842e-02 | 1.100 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 8.426750e-02 | 1.074 | 0 | 0 |
| IRS activation | R-HSA-74713 | 8.426750e-02 | 1.074 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 8.426750e-02 | 1.074 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.568677e-02 | 1.067 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.568677e-02 | 1.067 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.596813e-02 | 1.066 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.667936e-02 | 1.062 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.688630e-02 | 1.061 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.739375e-02 | 1.059 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.779203e-02 | 1.057 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.779203e-02 | 1.057 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.837737e-02 | 1.054 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.837737e-02 | 1.054 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.850699e-02 | 1.053 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.850699e-02 | 1.053 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.873651e-02 | 1.052 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.044263e-02 | 1.044 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.044263e-02 | 1.044 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.131314e-02 | 1.039 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.185187e-02 | 1.037 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.194620e-02 | 1.036 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.194620e-02 | 1.036 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.337303e-02 | 1.030 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.445947e-02 | 1.025 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.469904e-02 | 1.024 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.707642e-02 | 1.013 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.773478e-02 | 1.010 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.844346e-02 | 1.007 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.855135e-02 | 1.006 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.004821e-01 | 0.998 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.009285e-01 | 0.996 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.009285e-01 | 0.996 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.009285e-01 | 0.996 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.009285e-01 | 0.996 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.009285e-01 | 0.996 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.009285e-01 | 0.996 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.010317e-01 | 0.996 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.010317e-01 | 0.996 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.031058e-01 | 0.987 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.031312e-01 | 0.987 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.035369e-01 | 0.985 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.035369e-01 | 0.985 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.038860e-01 | 0.983 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.038860e-01 | 0.983 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.043680e-01 | 0.981 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.048293e-01 | 0.980 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.061794e-01 | 0.974 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.061794e-01 | 0.974 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.061794e-01 | 0.974 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.061794e-01 | 0.974 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.061794e-01 | 0.974 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.064775e-01 | 0.973 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.064775e-01 | 0.973 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.068040e-01 | 0.971 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.068040e-01 | 0.971 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 1.357905e-01 | 0.867 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.357905e-01 | 0.867 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.357905e-01 | 0.867 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.357905e-01 | 0.867 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.357905e-01 | 0.867 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.165606e-01 | 0.933 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.165606e-01 | 0.933 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.165606e-01 | 0.933 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.165606e-01 | 0.933 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.165606e-01 | 0.933 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.165606e-01 | 0.933 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.165606e-01 | 0.933 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.165606e-01 | 0.933 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.165606e-01 | 0.933 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.165606e-01 | 0.933 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.134953e-01 | 0.945 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.506592e-01 | 0.822 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.506592e-01 | 0.822 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.506592e-01 | 0.822 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.506592e-01 | 0.822 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.506592e-01 | 0.822 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.479974e-01 | 0.830 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.479974e-01 | 0.830 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.479974e-01 | 0.830 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.238743e-01 | 0.907 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.146446e-01 | 0.941 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.146446e-01 | 0.941 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.446405e-01 | 0.840 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.446405e-01 | 0.840 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.281481e-01 | 0.892 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.609505e-01 | 0.793 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.609505e-01 | 0.793 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.168034e-01 | 0.933 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.551914e-01 | 0.809 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.479192e-01 | 0.830 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.383651e-01 | 0.859 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.605024e-01 | 0.795 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.526285e-01 | 0.816 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.401005e-01 | 0.854 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.583252e-01 | 0.800 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.583252e-01 | 0.800 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.605024e-01 | 0.795 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.425630e-01 | 0.846 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.333715e-01 | 0.875 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.446405e-01 | 0.840 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.551914e-01 | 0.809 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.291917e-01 | 0.889 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.165606e-01 | 0.933 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.320353e-01 | 0.879 | 1 | 1 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.451467e-01 | 0.838 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.262893e-01 | 0.899 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.156603e-01 | 0.937 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.258207e-01 | 0.900 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.168034e-01 | 0.933 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.446405e-01 | 0.840 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.223377e-01 | 0.912 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.413323e-01 | 0.850 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.325505e-01 | 0.878 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.181365e-01 | 0.928 | 1 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.247369e-01 | 0.904 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.262893e-01 | 0.899 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.507847e-01 | 0.822 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.238743e-01 | 0.907 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.223377e-01 | 0.912 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.262140e-01 | 0.899 | 1 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.325505e-01 | 0.878 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.243905e-01 | 0.905 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.413323e-01 | 0.850 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.360497e-01 | 0.866 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.401907e-01 | 0.853 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.414852e-01 | 0.849 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.175299e-01 | 0.930 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.223377e-01 | 0.912 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.512782e-01 | 0.820 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.506592e-01 | 0.822 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.521525e-01 | 0.818 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.247369e-01 | 0.904 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.196662e-01 | 0.922 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.196662e-01 | 0.922 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.281481e-01 | 0.892 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.146446e-01 | 0.941 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.534660e-01 | 0.814 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.534660e-01 | 0.814 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.205815e-01 | 0.919 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.619463e-01 | 0.791 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.624583e-01 | 0.789 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.624583e-01 | 0.789 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.625964e-01 | 0.789 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.628184e-01 | 0.788 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.661334e-01 | 0.780 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.661334e-01 | 0.780 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.661693e-01 | 0.779 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.661693e-01 | 0.779 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.661693e-01 | 0.779 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.661693e-01 | 0.779 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.670983e-01 | 0.777 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.691487e-01 | 0.772 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.696993e-01 | 0.770 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.696993e-01 | 0.770 | 1 | 1 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.705796e-01 | 0.768 | 1 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.711579e-01 | 0.767 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.711579e-01 | 0.767 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.711579e-01 | 0.767 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.718530e-01 | 0.765 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.718530e-01 | 0.765 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.718530e-01 | 0.765 | 1 | 1 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.773659e-01 | 0.751 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.780741e-01 | 0.749 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.780741e-01 | 0.749 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.780741e-01 | 0.749 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.784213e-01 | 0.749 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.784213e-01 | 0.749 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.784213e-01 | 0.749 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.784213e-01 | 0.749 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.784213e-01 | 0.749 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.790092e-01 | 0.747 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.805839e-01 | 0.743 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.805839e-01 | 0.743 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.805839e-01 | 0.743 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.809802e-01 | 0.742 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.809802e-01 | 0.742 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.809802e-01 | 0.742 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.809802e-01 | 0.742 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.834624e-01 | 0.736 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.848257e-01 | 0.733 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.848257e-01 | 0.733 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.852390e-01 | 0.732 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.872026e-01 | 0.728 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.872026e-01 | 0.728 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.907541e-01 | 0.720 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.947007e-01 | 0.711 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.947007e-01 | 0.711 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.956091e-01 | 0.709 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.956091e-01 | 0.709 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.956091e-01 | 0.709 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.975411e-01 | 0.704 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.988945e-01 | 0.701 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.000150e-01 | 0.699 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.012031e-01 | 0.696 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.012570e-01 | 0.696 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.012570e-01 | 0.696 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.054668e-01 | 0.687 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.054668e-01 | 0.687 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.076662e-01 | 0.683 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.077316e-01 | 0.682 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.077316e-01 | 0.682 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.077316e-01 | 0.682 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.077316e-01 | 0.682 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.077316e-01 | 0.682 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.077316e-01 | 0.682 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.077316e-01 | 0.682 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.077316e-01 | 0.682 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.090790e-01 | 0.680 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.096593e-01 | 0.678 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.096593e-01 | 0.678 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.111907e-01 | 0.675 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.112482e-01 | 0.675 | 1 | 1 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.112482e-01 | 0.675 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.531487e-01 | 0.597 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.531487e-01 | 0.597 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.531487e-01 | 0.597 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) | R-HSA-5619088 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.531487e-01 | 0.597 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.531487e-01 | 0.597 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.185989e-01 | 0.660 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.185989e-01 | 0.660 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.185989e-01 | 0.660 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.185989e-01 | 0.660 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.545757e-01 | 0.450 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.545757e-01 | 0.450 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.545757e-01 | 0.450 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) | R-HSA-5619048 | 3.545757e-01 | 0.450 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 3.545757e-01 | 0.450 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.545757e-01 | 0.450 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.545757e-01 | 0.450 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.545757e-01 | 0.450 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.545757e-01 | 0.450 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.545757e-01 | 0.450 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.545757e-01 | 0.450 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.721696e-01 | 0.565 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.721696e-01 | 0.565 | 1 | 1 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.721696e-01 | 0.565 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.721696e-01 | 0.565 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.721696e-01 | 0.565 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.179748e-01 | 0.662 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.256052e-01 | 0.487 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.256052e-01 | 0.487 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.256052e-01 | 0.487 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.955023e-01 | 0.529 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.211781e-01 | 0.655 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.698041e-01 | 0.569 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.779549e-01 | 0.423 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.779549e-01 | 0.423 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.779549e-01 | 0.423 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.476852e-01 | 0.606 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 3.349921e-01 | 0.475 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.019819e-01 | 0.520 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.019819e-01 | 0.520 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.019819e-01 | 0.520 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.019819e-01 | 0.520 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.145419e-01 | 0.668 | 1 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.535898e-01 | 0.596 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.762956e-01 | 0.559 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.762956e-01 | 0.559 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.345514e-01 | 0.476 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.345514e-01 | 0.476 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.743677e-01 | 0.427 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.285286e-01 | 0.368 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.285286e-01 | 0.368 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.285286e-01 | 0.368 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.285286e-01 | 0.368 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 4.285286e-01 | 0.368 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.672577e-01 | 0.435 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.672577e-01 | 0.435 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.262839e-01 | 0.486 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.132564e-01 | 0.384 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.132564e-01 | 0.384 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.684361e-01 | 0.571 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.652499e-01 | 0.576 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.618986e-01 | 0.582 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.156353e-01 | 0.501 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.517351e-01 | 0.454 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.517351e-01 | 0.454 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.822195e-01 | 0.549 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.101922e-01 | 0.508 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.880122e-01 | 0.411 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.994996e-01 | 0.524 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.773311e-01 | 0.423 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.773311e-01 | 0.423 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.675703e-01 | 0.435 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.348271e-01 | 0.475 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.029581e-01 | 0.395 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.910205e-01 | 0.408 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.703983e-01 | 0.431 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.285083e-01 | 0.368 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.369894e-01 | 0.472 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.835449e-01 | 0.547 | 1 | 1 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.145419e-01 | 0.668 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.525026e-01 | 0.598 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.525026e-01 | 0.598 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.126547e-01 | 0.505 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.126547e-01 | 0.505 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.145419e-01 | 0.668 | 1 | 1 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.126547e-01 | 0.505 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.802516e-01 | 0.420 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.743677e-01 | 0.427 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.132564e-01 | 0.384 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.382914e-01 | 0.623 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.210503e-01 | 0.493 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.320943e-01 | 0.634 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.535898e-01 | 0.596 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.507885e-01 | 0.601 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.501485e-01 | 0.456 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.910205e-01 | 0.408 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.703983e-01 | 0.431 | 1 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.019819e-01 | 0.520 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.738445e-01 | 0.562 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.713545e-01 | 0.566 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.289106e-01 | 0.640 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.957813e-01 | 0.403 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.202180e-01 | 0.377 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.307856e-01 | 0.637 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.179748e-01 | 0.662 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.955023e-01 | 0.529 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.019819e-01 | 0.520 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.285286e-01 | 0.368 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.998672e-01 | 0.398 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.549501e-01 | 0.594 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.442172e-01 | 0.463 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.958595e-01 | 0.529 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.111515e-01 | 0.386 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.418691e-01 | 0.616 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.721696e-01 | 0.565 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.563320e-01 | 0.591 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.382914e-01 | 0.623 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.285286e-01 | 0.368 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.672577e-01 | 0.435 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.210503e-01 | 0.493 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.220022e-01 | 0.654 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.382041e-01 | 0.471 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.382041e-01 | 0.471 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.118541e-01 | 0.506 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.179748e-01 | 0.662 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.779549e-01 | 0.423 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.310210e-01 | 0.480 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.525026e-01 | 0.598 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.164555e-01 | 0.380 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.491624e-01 | 0.604 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.882760e-01 | 0.540 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.713545e-01 | 0.566 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.185989e-01 | 0.660 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.721696e-01 | 0.565 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.563320e-01 | 0.591 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.211781e-01 | 0.655 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.196247e-01 | 0.658 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.675703e-01 | 0.435 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.020181e-01 | 0.396 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.020181e-01 | 0.396 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.144821e-01 | 0.382 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.536756e-01 | 0.451 | 1 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.145419e-01 | 0.668 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.300602e-01 | 0.481 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.886453e-01 | 0.540 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.185989e-01 | 0.660 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.256052e-01 | 0.487 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.256052e-01 | 0.487 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.955023e-01 | 0.529 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.743677e-01 | 0.427 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.442172e-01 | 0.463 | 1 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.442172e-01 | 0.463 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.170493e-01 | 0.499 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.750035e-01 | 0.561 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.563320e-01 | 0.591 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.955023e-01 | 0.529 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.955023e-01 | 0.529 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.779549e-01 | 0.423 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.749481e-01 | 0.561 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 4.285286e-01 | 0.368 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.392037e-01 | 0.621 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 3.027858e-01 | 0.519 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.957813e-01 | 0.403 | 1 | 1 |
| Signaling by ALK | R-HSA-201556 | 3.585521e-01 | 0.445 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.804862e-01 | 0.552 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.545360e-01 | 0.594 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.185989e-01 | 0.660 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.545757e-01 | 0.450 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.545757e-01 | 0.450 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.545757e-01 | 0.450 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.545757e-01 | 0.450 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.545757e-01 | 0.450 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 2.721696e-01 | 0.565 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.132564e-01 | 0.384 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.549501e-01 | 0.594 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.233842e-01 | 0.490 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.172958e-01 | 0.499 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.804367e-01 | 0.420 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.501485e-01 | 0.456 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.904987e-01 | 0.537 | 1 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.250144e-01 | 0.488 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.038260e-01 | 0.517 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.157588e-01 | 0.501 | 1 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.144821e-01 | 0.382 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.320943e-01 | 0.634 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.594837e-01 | 0.444 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.256797e-01 | 0.371 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.211781e-01 | 0.655 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.779549e-01 | 0.423 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.132564e-01 | 0.384 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.132564e-01 | 0.384 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.132564e-01 | 0.384 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.675703e-01 | 0.435 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.910205e-01 | 0.408 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.910205e-01 | 0.408 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.703983e-01 | 0.431 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.868100e-01 | 0.413 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.027858e-01 | 0.519 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.101200e-01 | 0.387 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.545757e-01 | 0.450 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.349921e-01 | 0.475 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.145419e-01 | 0.668 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.880122e-01 | 0.411 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.442172e-01 | 0.463 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.310210e-01 | 0.480 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.170883e-01 | 0.663 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.883814e-01 | 0.411 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.164555e-01 | 0.380 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.721696e-01 | 0.565 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.285286e-01 | 0.368 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.594837e-01 | 0.444 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.348271e-01 | 0.475 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.620125e-01 | 0.441 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.262839e-01 | 0.486 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.698041e-01 | 0.569 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.920357e-01 | 0.407 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.164555e-01 | 0.380 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.019992e-01 | 0.396 | 1 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.302644e-01 | 0.481 | 1 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.256052e-01 | 0.487 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.672577e-01 | 0.435 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.349921e-01 | 0.475 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.345514e-01 | 0.476 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.458229e-01 | 0.461 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.306060e-01 | 0.366 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.316329e-01 | 0.365 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.321693e-01 | 0.364 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.321693e-01 | 0.364 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.321693e-01 | 0.364 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.369491e-01 | 0.360 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.378732e-01 | 0.359 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.378732e-01 | 0.359 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.407498e-01 | 0.356 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.422334e-01 | 0.354 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.422334e-01 | 0.354 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.422334e-01 | 0.354 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 4.422334e-01 | 0.354 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.422334e-01 | 0.354 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.422334e-01 | 0.354 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.422334e-01 | 0.354 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.422334e-01 | 0.354 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.422334e-01 | 0.354 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.422334e-01 | 0.354 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 4.422334e-01 | 0.354 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.426833e-01 | 0.354 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.439578e-01 | 0.353 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.446743e-01 | 0.352 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.501467e-01 | 0.347 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.501467e-01 | 0.347 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.513446e-01 | 0.345 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.513446e-01 | 0.345 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.513446e-01 | 0.345 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.514497e-01 | 0.345 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.538808e-01 | 0.343 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.573668e-01 | 0.340 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.611164e-01 | 0.336 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.634866e-01 | 0.334 | 1 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.639774e-01 | 0.334 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.670575e-01 | 0.331 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.689997e-01 | 0.329 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.725415e-01 | 0.326 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.768005e-01 | 0.322 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.768005e-01 | 0.322 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.768432e-01 | 0.322 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.768432e-01 | 0.322 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.768432e-01 | 0.322 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.827753e-01 | 0.316 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.881902e-01 | 0.311 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.883748e-01 | 0.311 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.883748e-01 | 0.311 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.883748e-01 | 0.311 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.884451e-01 | 0.311 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.951288e-01 | 0.305 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.999433e-01 | 0.301 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.999433e-01 | 0.301 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.999433e-01 | 0.301 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.009551e-01 | 0.300 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.037268e-01 | 0.298 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.037268e-01 | 0.298 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.068749e-01 | 0.295 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.095928e-01 | 0.293 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.120002e-01 | 0.291 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.120002e-01 | 0.291 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.141726e-01 | 0.289 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.160140e-01 | 0.287 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.164438e-01 | 0.287 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.164438e-01 | 0.287 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.179903e-01 | 0.286 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.179903e-01 | 0.286 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 5.179903e-01 | 0.286 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 5.179903e-01 | 0.286 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.179903e-01 | 0.286 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.179903e-01 | 0.286 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 5.179903e-01 | 0.286 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.179903e-01 | 0.286 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.179903e-01 | 0.286 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 5.179903e-01 | 0.286 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.180002e-01 | 0.286 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.184044e-01 | 0.285 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.197171e-01 | 0.284 | 1 | 1 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.225796e-01 | 0.282 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.225796e-01 | 0.282 | 1 | 1 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.225796e-01 | 0.282 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.225796e-01 | 0.282 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.225796e-01 | 0.282 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.225796e-01 | 0.282 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.225796e-01 | 0.282 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.225796e-01 | 0.282 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.225796e-01 | 0.282 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.225796e-01 | 0.282 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.225796e-01 | 0.282 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.241411e-01 | 0.281 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.241411e-01 | 0.281 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.241411e-01 | 0.281 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.254847e-01 | 0.279 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.254847e-01 | 0.279 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 5.254847e-01 | 0.279 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 5.254847e-01 | 0.279 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.254847e-01 | 0.279 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.254847e-01 | 0.279 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.267787e-01 | 0.278 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.280376e-01 | 0.277 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.295131e-01 | 0.276 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.304499e-01 | 0.275 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.304499e-01 | 0.275 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.316038e-01 | 0.274 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.327246e-01 | 0.273 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.327246e-01 | 0.273 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.509701e-01 | 0.259 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.512462e-01 | 0.259 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.515496e-01 | 0.258 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.549287e-01 | 0.256 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.549287e-01 | 0.256 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.584847e-01 | 0.253 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.584847e-01 | 0.253 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.584847e-01 | 0.253 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.584847e-01 | 0.253 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.584847e-01 | 0.253 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.584847e-01 | 0.253 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.655471e-01 | 0.248 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.655471e-01 | 0.248 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.655471e-01 | 0.248 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.655471e-01 | 0.248 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.655471e-01 | 0.248 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.655471e-01 | 0.248 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 5.655471e-01 | 0.248 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.655471e-01 | 0.248 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.655471e-01 | 0.248 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.675005e-01 | 0.246 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.675133e-01 | 0.246 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.690469e-01 | 0.245 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.727696e-01 | 0.242 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.784111e-01 | 0.238 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.784111e-01 | 0.238 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.784111e-01 | 0.238 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.815957e-01 | 0.235 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.833662e-01 | 0.234 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.833662e-01 | 0.234 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.833662e-01 | 0.234 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.834615e-01 | 0.234 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.834615e-01 | 0.234 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.834615e-01 | 0.234 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.834615e-01 | 0.234 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 5.834615e-01 | 0.234 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.834615e-01 | 0.234 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.834615e-01 | 0.234 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.834615e-01 | 0.234 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.834615e-01 | 0.234 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.834615e-01 | 0.234 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.834615e-01 | 0.234 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.912885e-01 | 0.228 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.912885e-01 | 0.228 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.912885e-01 | 0.228 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.912885e-01 | 0.228 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.977169e-01 | 0.224 | 1 | 1 |
| Triglyceride catabolism | R-HSA-163560 | 5.977169e-01 | 0.224 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.977169e-01 | 0.224 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.056539e-01 | 0.218 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.056539e-01 | 0.218 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.056539e-01 | 0.218 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 6.056539e-01 | 0.218 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.107225e-01 | 0.214 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.107225e-01 | 0.214 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.107225e-01 | 0.214 | 1 | 1 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.137526e-01 | 0.212 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.142850e-01 | 0.212 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.142850e-01 | 0.212 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.152816e-01 | 0.211 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.224724e-01 | 0.206 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.224724e-01 | 0.206 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.224724e-01 | 0.206 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.224724e-01 | 0.206 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.224724e-01 | 0.206 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.224724e-01 | 0.206 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.256861e-01 | 0.204 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.288990e-01 | 0.201 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.311675e-01 | 0.200 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.350314e-01 | 0.197 | 1 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.369413e-01 | 0.196 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.369413e-01 | 0.196 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.380283e-01 | 0.195 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.400431e-01 | 0.194 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.400431e-01 | 0.194 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.400431e-01 | 0.194 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.400431e-01 | 0.194 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.400431e-01 | 0.194 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.400431e-01 | 0.194 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.400431e-01 | 0.194 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.400431e-01 | 0.194 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.400431e-01 | 0.194 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.400431e-01 | 0.194 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.400431e-01 | 0.194 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.400431e-01 | 0.194 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.400431e-01 | 0.194 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.400431e-01 | 0.194 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 6.400431e-01 | 0.194 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.400431e-01 | 0.194 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.400431e-01 | 0.194 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.400431e-01 | 0.194 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.409513e-01 | 0.193 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.424123e-01 | 0.192 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.428844e-01 | 0.192 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.428844e-01 | 0.192 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.428844e-01 | 0.192 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.428844e-01 | 0.192 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.428844e-01 | 0.192 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.428844e-01 | 0.192 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.444203e-01 | 0.191 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.473180e-01 | 0.189 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.482834e-01 | 0.188 | 1 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.491747e-01 | 0.188 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.498164e-01 | 0.187 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.519877e-01 | 0.186 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.519877e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.535186e-01 | 0.185 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.573237e-01 | 0.182 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.614910e-01 | 0.179 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.614910e-01 | 0.179 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.614910e-01 | 0.179 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.619831e-01 | 0.179 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.649415e-01 | 0.177 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.650302e-01 | 0.177 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.698189e-01 | 0.174 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.708490e-01 | 0.173 | 1 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.722130e-01 | 0.172 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.742949e-01 | 0.171 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.754506e-01 | 0.170 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.772799e-01 | 0.169 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.772799e-01 | 0.169 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.772799e-01 | 0.169 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.772799e-01 | 0.169 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.798133e-01 | 0.168 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.798133e-01 | 0.168 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.798133e-01 | 0.168 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.798133e-01 | 0.168 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.812793e-01 | 0.167 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.812793e-01 | 0.167 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.812793e-01 | 0.167 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.812793e-01 | 0.167 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.821527e-01 | 0.166 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.858236e-01 | 0.164 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.858236e-01 | 0.164 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 6.858236e-01 | 0.164 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.858236e-01 | 0.164 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.889415e-01 | 0.162 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.889415e-01 | 0.162 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.889415e-01 | 0.162 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.889415e-01 | 0.162 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.889415e-01 | 0.162 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.889415e-01 | 0.162 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.889415e-01 | 0.162 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.889415e-01 | 0.162 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.889415e-01 | 0.162 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.889415e-01 | 0.162 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.889415e-01 | 0.162 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.889415e-01 | 0.162 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.889415e-01 | 0.162 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 6.889415e-01 | 0.162 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.889415e-01 | 0.162 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.889415e-01 | 0.162 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.889415e-01 | 0.162 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.889415e-01 | 0.162 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.889415e-01 | 0.162 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.889415e-01 | 0.162 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 6.889415e-01 | 0.162 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.889415e-01 | 0.162 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.889415e-01 | 0.162 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.892646e-01 | 0.162 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.914339e-01 | 0.160 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.943268e-01 | 0.158 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.988038e-01 | 0.156 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.059506e-01 | 0.151 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.067041e-01 | 0.151 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.067041e-01 | 0.151 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.084515e-01 | 0.150 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.084515e-01 | 0.150 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.084515e-01 | 0.150 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.089236e-01 | 0.149 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.089236e-01 | 0.149 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.112285e-01 | 0.148 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.130499e-01 | 0.147 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.130499e-01 | 0.147 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.130499e-01 | 0.147 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.131051e-01 | 0.147 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.142734e-01 | 0.146 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.146424e-01 | 0.146 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.148840e-01 | 0.146 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.185408e-01 | 0.144 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.185408e-01 | 0.144 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.185408e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.185408e-01 | 0.144 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.185408e-01 | 0.144 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.244034e-01 | 0.140 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.251283e-01 | 0.140 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.286770e-01 | 0.137 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.290455e-01 | 0.137 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.298674e-01 | 0.137 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.298674e-01 | 0.137 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.304201e-01 | 0.136 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.304201e-01 | 0.136 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.304201e-01 | 0.136 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.311998e-01 | 0.136 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.311998e-01 | 0.136 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 7.311998e-01 | 0.136 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 7.311998e-01 | 0.136 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 7.311998e-01 | 0.136 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.311998e-01 | 0.136 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.311998e-01 | 0.136 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.311998e-01 | 0.136 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.311998e-01 | 0.136 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 7.311998e-01 | 0.136 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.311998e-01 | 0.136 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.311998e-01 | 0.136 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.311998e-01 | 0.136 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 7.311998e-01 | 0.136 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.311998e-01 | 0.136 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.379283e-01 | 0.132 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.379283e-01 | 0.132 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.379283e-01 | 0.132 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.379283e-01 | 0.132 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.379283e-01 | 0.132 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.415446e-01 | 0.130 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.422365e-01 | 0.129 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.453046e-01 | 0.128 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.453046e-01 | 0.128 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.484351e-01 | 0.126 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.504669e-01 | 0.125 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.504669e-01 | 0.125 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.526697e-01 | 0.123 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.532575e-01 | 0.123 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.644268e-01 | 0.117 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.644268e-01 | 0.117 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.644268e-01 | 0.117 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.644268e-01 | 0.117 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.644268e-01 | 0.117 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.644268e-01 | 0.117 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 7.644268e-01 | 0.117 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.677193e-01 | 0.115 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.677193e-01 | 0.115 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.677193e-01 | 0.115 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.677193e-01 | 0.115 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.677193e-01 | 0.115 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.677193e-01 | 0.115 | 0 | 0 |
| Opsins | R-HSA-419771 | 7.677193e-01 | 0.115 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.677193e-01 | 0.115 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.677193e-01 | 0.115 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.677193e-01 | 0.115 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.677193e-01 | 0.115 | 0 | 0 |
| Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | R-HSA-9026762 | 7.677193e-01 | 0.115 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.677193e-01 | 0.115 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.677600e-01 | 0.115 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.690173e-01 | 0.114 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.691142e-01 | 0.114 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.723409e-01 | 0.112 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.745109e-01 | 0.111 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.745109e-01 | 0.111 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.745109e-01 | 0.111 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.766367e-01 | 0.110 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.836789e-01 | 0.106 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.885647e-01 | 0.103 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.885647e-01 | 0.103 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.885647e-01 | 0.103 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.889501e-01 | 0.103 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.919834e-01 | 0.101 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.942376e-01 | 0.100 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.942376e-01 | 0.100 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.942376e-01 | 0.100 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.942376e-01 | 0.100 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.942376e-01 | 0.100 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.942376e-01 | 0.100 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.980354e-01 | 0.098 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.982101e-01 | 0.098 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.992790e-01 | 0.097 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.992790e-01 | 0.097 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.992790e-01 | 0.097 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.992790e-01 | 0.097 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.992790e-01 | 0.097 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.992790e-01 | 0.097 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.992790e-01 | 0.097 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.992790e-01 | 0.097 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.992790e-01 | 0.097 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.992790e-01 | 0.097 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.992790e-01 | 0.097 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.992790e-01 | 0.097 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.992790e-01 | 0.097 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.995835e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.031192e-01 | 0.095 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.083801e-01 | 0.092 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.104942e-01 | 0.091 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.104942e-01 | 0.091 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.104942e-01 | 0.091 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.104942e-01 | 0.091 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.111857e-01 | 0.091 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.116447e-01 | 0.091 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.122826e-01 | 0.090 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.125020e-01 | 0.090 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.141542e-01 | 0.089 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.141542e-01 | 0.089 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.229878e-01 | 0.085 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.242480e-01 | 0.084 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.245239e-01 | 0.084 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.265523e-01 | 0.083 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.265523e-01 | 0.083 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.265523e-01 | 0.083 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.265523e-01 | 0.083 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.265523e-01 | 0.083 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.265523e-01 | 0.083 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.265523e-01 | 0.083 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.265523e-01 | 0.083 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.265523e-01 | 0.083 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.265523e-01 | 0.083 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.265523e-01 | 0.083 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.265523e-01 | 0.083 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.293735e-01 | 0.081 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.293735e-01 | 0.081 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.303696e-01 | 0.081 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.303696e-01 | 0.081 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.303696e-01 | 0.081 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.303696e-01 | 0.081 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.318243e-01 | 0.080 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.318243e-01 | 0.080 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.340292e-01 | 0.079 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.340292e-01 | 0.079 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.340292e-01 | 0.079 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.407397e-01 | 0.075 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.407397e-01 | 0.075 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.407397e-01 | 0.075 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.421344e-01 | 0.075 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.433297e-01 | 0.074 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.442363e-01 | 0.074 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.442589e-01 | 0.074 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.449247e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.449247e-01 | 0.073 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.449247e-01 | 0.073 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.452893e-01 | 0.073 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.476468e-01 | 0.072 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.476468e-01 | 0.072 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.481710e-01 | 0.072 | 1 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.483443e-01 | 0.071 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.483443e-01 | 0.071 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.483443e-01 | 0.071 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.483443e-01 | 0.071 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.483443e-01 | 0.071 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.483443e-01 | 0.071 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.483443e-01 | 0.071 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.483443e-01 | 0.071 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.483443e-01 | 0.071 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.501212e-01 | 0.071 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.501212e-01 | 0.071 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.501212e-01 | 0.071 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.501212e-01 | 0.071 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.501212e-01 | 0.071 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.501212e-01 | 0.071 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.501212e-01 | 0.071 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.501212e-01 | 0.071 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.501212e-01 | 0.071 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.501212e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.528125e-01 | 0.069 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.555457e-01 | 0.068 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.557470e-01 | 0.068 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.557470e-01 | 0.068 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.573912e-01 | 0.067 | 1 | 0 |
| Ion channel transport | R-HSA-983712 | 8.589649e-01 | 0.066 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.592298e-01 | 0.066 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.592298e-01 | 0.066 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.592298e-01 | 0.066 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.603074e-01 | 0.065 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.611967e-01 | 0.065 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.631986e-01 | 0.064 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.632022e-01 | 0.064 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.632022e-01 | 0.064 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.640163e-01 | 0.063 | 1 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.645676e-01 | 0.063 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.645676e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.645676e-01 | 0.063 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.645676e-01 | 0.063 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.686218e-01 | 0.061 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.703965e-01 | 0.060 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.704886e-01 | 0.060 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.704886e-01 | 0.060 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.704886e-01 | 0.060 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.704886e-01 | 0.060 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.704886e-01 | 0.060 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.704886e-01 | 0.060 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 8.704886e-01 | 0.060 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.704886e-01 | 0.060 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.704886e-01 | 0.060 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.720576e-01 | 0.059 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.720576e-01 | 0.059 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.720668e-01 | 0.059 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.723638e-01 | 0.059 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.723638e-01 | 0.059 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.723638e-01 | 0.059 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.723638e-01 | 0.059 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.747188e-01 | 0.058 | 1 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.749542e-01 | 0.058 | 1 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.766415e-01 | 0.057 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.784967e-01 | 0.056 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.791836e-01 | 0.056 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.791836e-01 | 0.056 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.791836e-01 | 0.056 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.791836e-01 | 0.056 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.834012e-01 | 0.054 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.834026e-01 | 0.054 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.844009e-01 | 0.053 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.844009e-01 | 0.053 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.845312e-01 | 0.053 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.845312e-01 | 0.053 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.845312e-01 | 0.053 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.880892e-01 | 0.052 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.880892e-01 | 0.052 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.880892e-01 | 0.052 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.880892e-01 | 0.052 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.880892e-01 | 0.052 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.880892e-01 | 0.052 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.880892e-01 | 0.052 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.880892e-01 | 0.052 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.880892e-01 | 0.052 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.880892e-01 | 0.052 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.883903e-01 | 0.051 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.923294e-01 | 0.049 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.923294e-01 | 0.049 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.930160e-01 | 0.049 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.937152e-01 | 0.049 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.951712e-01 | 0.048 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.954140e-01 | 0.048 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.954140e-01 | 0.048 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.992594e-01 | 0.046 | 1 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.992594e-01 | 0.046 | 1 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.029677e-01 | 0.044 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.032988e-01 | 0.044 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 9.032988e-01 | 0.044 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.032988e-01 | 0.044 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 9.032988e-01 | 0.044 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 9.032988e-01 | 0.044 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 9.032988e-01 | 0.044 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.032988e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.041346e-01 | 0.044 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.041346e-01 | 0.044 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.054741e-01 | 0.043 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.064764e-01 | 0.043 | 1 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.095920e-01 | 0.041 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.108307e-01 | 0.041 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.108982e-01 | 0.041 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.108982e-01 | 0.041 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.108982e-01 | 0.041 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.112246e-01 | 0.040 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.129913e-01 | 0.040 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.146499e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.147207e-01 | 0.039 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.147207e-01 | 0.039 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.158516e-01 | 0.038 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.164420e-01 | 0.038 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.164420e-01 | 0.038 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.164420e-01 | 0.038 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 9.164420e-01 | 0.038 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.174423e-01 | 0.037 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.175716e-01 | 0.037 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.193601e-01 | 0.037 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.195894e-01 | 0.036 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.200827e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.200827e-01 | 0.036 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.242009e-01 | 0.034 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.242009e-01 | 0.034 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.244414e-01 | 0.034 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.261839e-01 | 0.033 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.269799e-01 | 0.033 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.277995e-01 | 0.033 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.277995e-01 | 0.033 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.277995e-01 | 0.033 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.277995e-01 | 0.033 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.277995e-01 | 0.033 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.277995e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.277995e-01 | 0.033 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.286728e-01 | 0.032 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.287097e-01 | 0.032 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.306084e-01 | 0.031 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.307253e-01 | 0.031 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.324452e-01 | 0.030 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.326803e-01 | 0.030 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.326803e-01 | 0.030 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.326803e-01 | 0.030 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.327454e-01 | 0.030 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.327454e-01 | 0.030 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.327454e-01 | 0.030 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.342837e-01 | 0.030 | 1 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.360467e-01 | 0.029 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.362622e-01 | 0.029 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.362622e-01 | 0.029 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.365720e-01 | 0.028 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.375133e-01 | 0.028 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.375133e-01 | 0.028 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.375133e-01 | 0.028 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.375133e-01 | 0.028 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.376139e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.376139e-01 | 0.028 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.376139e-01 | 0.028 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.402557e-01 | 0.027 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.402557e-01 | 0.027 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.402557e-01 | 0.027 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.402557e-01 | 0.027 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.402557e-01 | 0.027 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.403819e-01 | 0.027 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.410999e-01 | 0.026 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.418530e-01 | 0.026 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.419718e-01 | 0.026 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.419718e-01 | 0.026 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.437778e-01 | 0.025 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.444848e-01 | 0.025 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.444848e-01 | 0.025 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.445597e-01 | 0.025 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.452515e-01 | 0.024 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.460946e-01 | 0.024 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.460946e-01 | 0.024 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.460946e-01 | 0.024 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.460946e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.460946e-01 | 0.024 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.460946e-01 | 0.024 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.460946e-01 | 0.024 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.461088e-01 | 0.024 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.462549e-01 | 0.024 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.470161e-01 | 0.024 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.470161e-01 | 0.024 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.477583e-01 | 0.023 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.478595e-01 | 0.023 | 1 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.496231e-01 | 0.022 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.496231e-01 | 0.022 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.501938e-01 | 0.022 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.504957e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.508213e-01 | 0.022 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.513996e-01 | 0.022 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.515447e-01 | 0.022 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.518711e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.530431e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.530431e-01 | 0.021 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.530431e-01 | 0.021 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.534229e-01 | 0.021 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.534229e-01 | 0.021 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.534229e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.534229e-01 | 0.021 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.543213e-01 | 0.020 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.559909e-01 | 0.020 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.568916e-01 | 0.019 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.584110e-01 | 0.018 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.592275e-01 | 0.018 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.597553e-01 | 0.018 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.597553e-01 | 0.018 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.597553e-01 | 0.018 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.597553e-01 | 0.018 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.597553e-01 | 0.018 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.607121e-01 | 0.017 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.620016e-01 | 0.017 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.631878e-01 | 0.016 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.631878e-01 | 0.016 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.634369e-01 | 0.016 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.634369e-01 | 0.016 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.638682e-01 | 0.016 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.639935e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.652271e-01 | 0.015 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.652271e-01 | 0.015 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.652271e-01 | 0.015 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.652271e-01 | 0.015 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.652271e-01 | 0.015 | 0 | 0 |
| Biosynthesis of DHA-derived sulfido conjugates | R-HSA-9026395 | 9.652271e-01 | 0.015 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.662758e-01 | 0.015 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.665093e-01 | 0.015 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.672244e-01 | 0.014 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.674348e-01 | 0.014 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.674348e-01 | 0.014 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.687821e-01 | 0.014 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.699552e-01 | 0.013 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.699552e-01 | 0.013 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.699552e-01 | 0.013 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.699552e-01 | 0.013 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.699552e-01 | 0.013 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.699552e-01 | 0.013 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.706392e-01 | 0.013 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.712077e-01 | 0.013 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.712077e-01 | 0.013 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.712077e-01 | 0.013 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.722716e-01 | 0.012 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.723049e-01 | 0.012 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.737151e-01 | 0.012 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.737151e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.740407e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.740407e-01 | 0.011 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.740407e-01 | 0.011 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.749932e-01 | 0.011 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.764835e-01 | 0.010 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.769125e-01 | 0.010 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.771657e-01 | 0.010 | 1 | 1 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.774349e-01 | 0.010 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.775281e-01 | 0.010 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.775708e-01 | 0.010 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.775978e-01 | 0.010 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.789729e-01 | 0.009 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.793890e-01 | 0.009 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.796507e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.801619e-01 | 0.009 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.806210e-01 | 0.008 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.806210e-01 | 0.008 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.806210e-01 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.812275e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.812662e-01 | 0.008 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.824951e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.828943e-01 | 0.007 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.829484e-01 | 0.007 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.832566e-01 | 0.007 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.832566e-01 | 0.007 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.832566e-01 | 0.007 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.832566e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.832566e-01 | 0.007 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.834441e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.840554e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.844279e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.851290e-01 | 0.007 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.854484e-01 | 0.006 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.855339e-01 | 0.006 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.855339e-01 | 0.006 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.855339e-01 | 0.006 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.855339e-01 | 0.006 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.855339e-01 | 0.006 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.855339e-01 | 0.006 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.858331e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.863885e-01 | 0.006 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.866203e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.866354e-01 | 0.006 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.872625e-01 | 0.006 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.875015e-01 | 0.005 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.875015e-01 | 0.005 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.875015e-01 | 0.005 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.875015e-01 | 0.005 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.875015e-01 | 0.005 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.875015e-01 | 0.005 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.875015e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.880048e-01 | 0.005 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.880048e-01 | 0.005 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.880048e-01 | 0.005 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.880827e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.890623e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.891084e-01 | 0.005 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.891867e-01 | 0.005 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.891867e-01 | 0.005 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.892016e-01 | 0.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.892016e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.894334e-01 | 0.005 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.902332e-01 | 0.004 | 1 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.906706e-01 | 0.004 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.906706e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.906706e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.906706e-01 | 0.004 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.906706e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.907145e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.907145e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.907145e-01 | 0.004 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.915064e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.918096e-01 | 0.004 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.919394e-01 | 0.004 | 1 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.919398e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.919398e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.919398e-01 | 0.004 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.919398e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.919398e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.919398e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.919398e-01 | 0.004 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.919398e-01 | 0.004 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.920372e-01 | 0.003 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.927930e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.927930e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.930183e-01 | 0.003 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.930364e-01 | 0.003 | 0 | 0 |
| Phosphate bond hydrolysis by NTPDase proteins | R-HSA-8850843 | 9.930364e-01 | 0.003 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.930364e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.930364e-01 | 0.003 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.930364e-01 | 0.003 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.931213e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.936605e-01 | 0.003 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.937560e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.939838e-01 | 0.003 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.944582e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.946034e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.947277e-01 | 0.002 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.948024e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.949258e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.955097e-01 | 0.002 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.956935e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.956935e-01 | 0.002 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.956935e-01 | 0.002 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.961207e-01 | 0.002 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.966486e-01 | 0.001 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.966486e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.966486e-01 | 0.001 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.966486e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.967560e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.967615e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.967615e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.970920e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.970920e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.970920e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.971047e-01 | 0.001 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.971047e-01 | 0.001 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.971047e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.972035e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.974211e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.974349e-01 | 0.001 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.974988e-01 | 0.001 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.974988e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.975874e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.977951e-01 | 0.001 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.978392e-01 | 0.001 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.978392e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.978392e-01 | 0.001 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.978392e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.979677e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.980282e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.980282e-01 | 0.001 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.983875e-01 | 0.001 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.983875e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.983875e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.983875e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.983875e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.984833e-01 | 0.001 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.984833e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.985351e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.985601e-01 | 0.001 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.986070e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.986070e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.986070e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.986070e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.986703e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.987966e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.987966e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988978e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.988978e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.989255e-01 | 0.000 | 1 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.990546e-01 | 0.000 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.991020e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.991020e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.991052e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.991379e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.991854e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.992378e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.993299e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.993989e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.994212e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.994262e-01 | 0.000 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.994738e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.994782e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994941e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.995000e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.995000e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995394e-01 | 0.000 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.995681e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.995681e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.995681e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.995831e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.995970e-01 | 0.000 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.996269e-01 | 0.000 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.996269e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.996275e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.996778e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.996778e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996807e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996968e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997183e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.997217e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.997217e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997447e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997596e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997634e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.997770e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997791e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997809e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.997907e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.997923e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997937e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997937e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.997944e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998206e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.998206e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.998229e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998941e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998948e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998974e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.999002e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999057e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999117e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999152e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999152e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999245e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999291e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999424e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999586e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999733e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999733e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999780e-01 | 0.000 | 1 | 1 |
| Nicotinate metabolism | R-HSA-196807 | 9.999828e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999863e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999889e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999904e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999917e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999917e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999917e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999920e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999920e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999929e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999936e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999947e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999951e-01 | 0.000 | 1 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999954e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999961e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999973e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999974e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999978e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999980e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999982e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999984e-01 | 0.000 | 1 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999994e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999998e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 1 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |